Category: Uncategorized

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Borderline personality disorder is a diagnosable mental health condition that requires professional evaluation. Only a qualified clinician can provide a diagnosis. If you believe you may be experiencing symptoms described here, please consult a mental health professional for a comprehensive assessment.

If you are in crisis or experiencing thoughts of self-harm or suicide: Call or text 988 (Suicide and Crisis Lifeline, available 24/7). Text HOME to 741741 (Crisis Text Line). For medical emergencies, call 911.

Contents

• What Is Borderline Personality Disorder?
• DSM-5 Criteria for BPD
• Symptoms of Borderline Personality Disorder
• What Causes Borderline Personality Disorder?
• BPD and Stigma: Separating Myth from Reality
• BPD and Co-Occurring Conditions
• Treatment for Borderline Personality Disorder
• Frequently Asked Questions

Borderline personality disorder (BPD) is a complex mental health condition characterized by pervasive instability in emotional regulation, self-image, interpersonal relationships, and behavior – often accompanied by an intense, sometimes desperate fear of real or imagined abandonment. Despite being one of the more common personality disorders – affecting approximately 1.6–5.9% of the general population – borderline personality disorder remains among the most stigmatized and misunderstood mental health diagnoses. People living with BPD are often characterized by others as “manipulative,” “dramatic,” or “difficult” – framings that are both clinically inaccurate and profoundly harmful. BPD is a condition with identifiable neurobiological underpinnings, clear developmental antecedents, and – critically – effective, evidence-based treatments. Recovery is possible.

What Is Borderline Personality Disorder?

Borderline personality disorder is classified in the DSM-5 as a personality disorder – a category of conditions involving enduring patterns of inner experience and behavior that deviate significantly from cultural expectations, are pervasive and inflexible, and cause significant distress or functional impairment. BPD specifically involves a marked instability across multiple domains – emotion, identity, relationships, and impulse control – with the fear of abandonment as a central organizing theme.

The name “borderline” is a historical artifact from an era when the condition was thought to exist on the “borderline” between neurosis and psychosis – a conceptualization that has since been abandoned. The name has contributed to persistent confusion and stigma, and some clinicians and advocates prefer alternative framings such as “emotionally unstable personality disorder” (used in the ICD-11) or “complex trauma disorder.” Regardless of the label, the clinical picture is consistent and well-characterized: a person whose emotional experience is extraordinarily intense, whose sense of self is fragile and shifting, and whose relationships are marked by cycles of idealization and profound disappointment.

DSM-5 Criteria for Borderline Personality Disorder

According to the DSM-5, a diagnosis of BPD requires a pervasive pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity, beginning by early adulthood and present in a variety of contexts, as indicated by five or more of the following nine criteria:

1. Frantic efforts to avoid real or imagined abandonment
2. A pattern of unstable and intense interpersonal relationships characterized by alternating between extremes of idealization and devaluation
3. Identity disturbance: markedly and persistently unstable self-image or sense of self
4. Impulsivity in at least two areas that are potentially self-damaging (e.g., spending, substance use, reckless driving, binge eating)
5. Recurrent suicidal behavior, gestures, or threats, or self-mutilating behavior
6. Affective instability due to a marked reactivity of mood (e.g., intense episodic dysphoria, irritability, or anxiety usually lasting a few hours and rarely more than a few days)
7. Chronic feelings of emptiness
8. Inappropriate, intense anger or difficulty controlling anger
9. Transient, stress-related paranoid ideation or severe dissociative symptoms

Because any five of the nine criteria can yield a diagnosis, there are 256 different combinations that qualify – which helps explain why people with BPD can present very differently from one another. Two individuals with BPD may share a diagnosis while having only one or two overlapping symptoms.

Symptoms of Borderline Personality Disorder

Emotional Dysregulation

Emotional dysregulation is often described as the core feature of BPD. Individuals with BPD experience emotions with an intensity and duration that is substantially greater than most people – what Marsha Linehan, the developer of DBT, described as “emotional third-degree burns.” Emotions arise quickly, reach peak intensity rapidly, and take longer to return to baseline. This is not a choice or a performance; it reflects genuine neurobiological differences in how the limbic system processes emotional stimuli.

The affective instability of BPD – rapid shifts between dysphoria, anxiety, irritability, and brief periods of well-being – is distinct from the sustained depressive or manic episodes of mood disorders. BPD moods typically shift in response to interpersonal events, particularly real or perceived rejection or abandonment, and cycle within hours rather than days or weeks.

Fear of Abandonment and Relationship Instability

Fear of abandonment – real or imagined – is often described as the most central and painful feature of BPD. A perceived slight, a delayed response to a message, or a friend’s cancelled plan can trigger an intense, disproportionate fear of being permanently rejected or left alone. This fear drives many of the interpersonal behaviors associated with BPD: urgent reassurance-seeking, difficulty tolerating aloneness, and the push-pull dynamic in close relationships.

Relationships in BPD are often characterized by a pattern of idealization and devaluation – sometimes called “splitting.” A person may be experienced as perfect, completely understanding, and uniquely attuned at one moment, and as completely rejecting, cruel, or worthless at another. This reflects a genuine difficulty integrating the positive and negative aspects of others into a coherent, stable internal representation – not manipulation or character defect.

Identity Disturbance

A markedly unstable sense of self is one of the most disorienting aspects of BPD from the inside. Individuals with BPD often describe feeling unsure of who they are – their values, goals, career direction, sexual identity, or fundamental preferences may feel shifting and unclear. This is not adolescent uncertainty; it is a pervasive, chronic instability that can persist into adulthood and significantly impair the ability to make long-term commitments and plans.

The chronic feelings of emptiness that many people with BPD describe are related to this identity instability – a profound sense of hollowness or meaninglessness that is distinct from depression and does not fully respond to external reassurance or distraction.

Impulsivity

Impulsivity in BPD manifests across domains: reckless spending, substance use, risky sexual behavior, binge eating, reckless driving, or self-destructive decision-making. These behaviors often function as attempts to regulate unbearable emotional states – to interrupt intense dysphoria, to feel something when numbness dominates, or to express pain that cannot be put into words. Understanding the emotion-regulation function of impulsive behavior is essential for effective treatment.

Self-Harm and Suicidality

Non-suicidal self-injury and suicidal behavior are among the most serious clinical features of BPD. Research indicates that approximately 70–75% of people with BPD engage in self-harm at some point, and the lifetime rate of completed suicide in BPD is estimated at approximately 8–10% – substantially higher than the general population. These figures underscore the clinical seriousness of BPD and the critical importance of access to evidence-based treatment.

Self-harm in BPD most commonly serves an emotion-regulation function – a way of interrupting overwhelming emotional states, expressing internal pain in a concrete way, or feeling something in the context of dissociation and emptiness. This does not mean it is not dangerous; it means that effective treatment must address the underlying emotional dysregulation, not just the behavior itself.

What Causes Borderline Personality Disorder?

BPD arises from an interaction of genetic, neurobiological, and environmental factors. No single cause accounts for all presentations.

Genetic and biological factors: BPD runs in families, with heritability estimates of approximately 40–60%. Neurobiologically, research has documented differences in the limbic system – particularly amygdala hyperreactivity – and in the prefrontal circuits that regulate emotion and impulse control. These differences contribute to the emotional intensity and reactivity characteristic of BPD.

Childhood trauma and adversity: Childhood trauma – including physical, emotional, and sexual abuse; neglect; and household instability – is among the most consistent findings in the developmental history of people with BPD. Studies suggest that 70–80% of people with BPD report histories of childhood trauma or neglect. However, BPD also occurs in the absence of overt trauma, suggesting that the relationship is contributory rather than deterministic.

Marsha Linehan’s biosocial theory: The most clinically influential developmental model of BPD is Linehan’s biosocial theory, which proposes that BPD develops from the interaction between a biologically sensitive emotional temperament and an invalidating childhood environment – one that chronically communicated that the child’s emotional experiences were wrong, inappropriate, or not to be taken seriously. This combination – high biological sensitivity plus insufficient validation and emotional coaching – is proposed to prevent the development of effective emotion-regulation skills, leaving the person with the intense, reactive emotional experience of BPD without the tools to manage it.

BPD and Stigma: Separating Myth from Reality

Few mental health diagnoses carry as much clinical stigma as BPD – including, unfortunately, stigma from within the mental health system itself. People with BPD have historically been described as “treatment-resistant,” “manipulative,” “attention-seeking,” or “untreatable” – characterizations that are not only inaccurate but have contributed to avoidance of diagnosis, inadequate care, and profound suffering.

The reality is that BPD is one of the most treatable severe mental health conditions. With access to evidence-based treatment – particularly DBT – meaningful improvement in quality of life, reduction in self-harm, and long-term remission are well-documented outcomes. The behaviors that are labeled “manipulative” by stigmatizing frameworks are more accurately understood as desperate attempts to manage unbearable emotional pain with an insufficient toolkit. The “treatment resistance” often attributed to BPD more accurately reflects the inadequacy of treatments that were not designed for BPD’s specific clinical profile.

BPD and Co-Occurring Conditions

BPD rarely presents in isolation. The most common co-occurring conditions include:

• Major depressive disorder – present in the majority of people with BPD at some point; the two conditions require differentiation because treatment approaches differ
• PTSD and complex PTSD – given the high rates of childhood trauma in BPD, co-occurring trauma disorders are extremely common and require integrated treatment
• Substance use disorders – substance use is common in BPD and often serves an emotion-regulation or dissociation-interruption function
• Eating disorders – particularly bulimia nervosa and binge eating disorder, which share an impulsivity and emotional dysregulation profile
• Bipolar disorder – BPD and bipolar disorder are frequently confused due to mood instability; careful differential diagnosis is important because pharmacological treatment differs significantly
• ADHD – impulsivity, emotional reactivity, and identity difficulties in ADHD overlap with BPD; both may be present

Treatment for Borderline Personality Disorder

Dialectical Behavior Therapy (DBT)

DBT is the gold-standard, most extensively researched treatment for BPD. Developed specifically for BPD by Marsha Linehan, DBT combines individual therapy with a skills training group addressing four modules: mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness. DBT has demonstrated efficacy in reducing self-harm, suicidality, hospitalizations, and emotional dysregulation in multiple randomized controlled trials. The full DBT program – individual therapy, skills group, phone coaching, and therapist consultation team – provides the most comprehensive support, particularly for individuals with significant self-harm or suicidality.

Cognitive Behavioral Therapy (CBT) and Schema Therapy

Cognitive behavioral therapy, and particularly schema therapy (an extension of CBT developed specifically for personality disorders), addresses the deeply held maladaptive beliefs – about self, others, and relationships – that maintain BPD patterns. Schema therapy identifies the early maladaptive schemas that developed in response to unmet childhood needs and works to modify them through cognitive, behavioral, and experiential techniques.

Trauma-Informed Care

Given the high rates of childhood trauma in BPD, trauma-informed treatment is often an essential component of comprehensive care. The trauma recovery program at Synchrony Brain Health provides integrated, neuroscience-informed care for individuals navigating the intersection of trauma history and personality disorder presentations – addressing both the developmental roots and the present-day symptoms of the condition.

Medication

No medication is FDA-approved specifically for BPD. However, medications may be used to target specific symptom domains – mood stabilizers or atypical antipsychotics for affective instability or impulsivity, antidepressants for co-occurring depression or anxiety. Medication is generally considered adjunctive to psychotherapy rather than the primary treatment for BPD. Prescribing decisions should always be made collaboratively with a qualified prescriber.

Neurofeedback

As an adjunct to psychotherapy, neurofeedback therapy may support nervous system regulation in individuals with BPD – addressing the neurobiological substrate of emotional hyperreactivity and building baseline regulatory capacity that supports engagement with skills-based treatment.

Frequently Asked Questions

Is borderline personality disorder the same as bipolar disorder?
No, though they are frequently confused. Both involve mood instability, but the pattern differs. In BPD, mood shifts are typically rapid (hours), triggered by interpersonal events, and accompanied by identity instability, fear of abandonment, and self-harm patterns. In bipolar disorder, mood episodes (mania/hypomania and depression) last days to weeks or months, occur somewhat independently of interpersonal triggers, and are not typically accompanied by the identity and relationship features of BPD. Both may co-occur in the same person, and careful differential diagnosis by a qualified clinician is important because pharmacological treatment differs significantly.

Can borderline personality disorder be cured?
“Cure” is not the most useful frame for understanding BPD recovery, but substantial and lasting improvement is well-documented. Long-term follow-up studies show that a majority of people with BPD no longer meet full diagnostic criteria after 10 years, particularly with access to effective treatment. DBT and other evidence-based approaches produce meaningful reductions in self-harm, suicidality, hospitalization, and emotional dysregulation. Recovery from BPD is real – it involves building the skills and self-understanding that were not available earlier in life.

Is BPD more common in women?
BPD has historically been diagnosed more frequently in women – approximately 75% of diagnosed cases in clinical settings. However, research suggests this may reflect diagnostic bias rather than true prevalence differences. Men with BPD may be more likely to be diagnosed with antisocial personality disorder or substance use disorders, as their behavioral expressions of the same underlying emotional dysregulation may manifest differently. Population-based studies find more equal gender distribution than clinical samples suggest.

Can people with BPD have healthy relationships?
Yes. With effective treatment – particularly DBT, which specifically targets the interpersonal skills that are most impaired in BPD – many people with BPD develop the capacity for stable, fulfilling relationships. The patterns of idealization, devaluation, and fear of abandonment that characterize untreated BPD are not fixed traits; they are patterns that developed in specific developmental contexts and can be changed through treatment, self-awareness, and the corrective experience of a therapeutic relationship.

Borderline personality disorder is serious – and it is treatable. The experience of BPD is often one of profound suffering: of emotions that feel uncontrollable, relationships that feel impossible, and a self that feels unsteady. Evidence-based treatment can change this. The clinicians at Synchrony Brain Health in Chicago offer trauma-informed, DBT-informed care for individuals with BPD and related conditions. If you are ready to explore what treatment can offer, we are here.

Citations: American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Linehan, M.M. (1993). Cognitive-behavioral treatment of borderline personality disorder. Guilford Press. Zanarini, M.C., et al. (2012). Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects. American Journal of Psychiatry, 169(5), 476–483. Leichsenring, F., et al. (2011). Borderline personality disorder. The Lancet, 377(9759), 74–84. Paris, J. (2019). Treatment of borderline personality disorder: A guide to evidence-based practice (2nd ed.). Guilford Press. Lieb, K., et al. (2004). Borderline personality disorder. The Lancet, 364(9432), 453–461. National Education Alliance for Borderline Personality Disorder (NEABPD). (2022). Retrieved from borderlinepersonalitydisorder.org.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. If you believe adverse childhood experiences may be affecting your mental or physical health, please consult a qualified mental health professional for a comprehensive evaluation.

If you are in crisis or need immediate support: Call or text 988 (Suicide and Crisis Lifeline, available 24/7). Text HOME to 741741 (Crisis Text Line). For medical emergencies, call 911.

 

Contents

• What Are Adverse Childhood Experiences (ACEs)?
• The ACE Study: What Research Found
• How ACEs Affect the Developing Brain
• ACEs and Long-Term Mental Health
• ACEs and Physical Health
• Protective Factors and Resilience
• Healing from ACEs: What Treatment Can Offer
• Frequently Asked Questions

Adverse childhood experiences – commonly referred to by the acronym ACEs – are potentially traumatic events that occur during childhood and have been shown to have profound, lasting effects on brain development, mental health, physical health, and life outcomes. The term comes from one of the largest and most influential studies in public health history: the ACE Study, conducted by the Centers for Disease Control and Prevention (CDC) and Kaiser Permanente in the 1990s. Understanding adverse childhood experiences is not about assigning blame or pathologizing the past. It is about making sense of why some adults carry burdens that began long before they had any choice in the matter – and about opening the door to the healing that is genuinely possible with the right support.

What Are Adverse Childhood Experiences (ACEs)?

The original ACE Study defined ten categories of adverse childhood experiences, grouped into three domains:

Abuse

• Physical abuse – being hit, beaten, kicked, or physically harmed by an adult in the household
• Emotional abuse – being repeatedly sworn at, humiliated, threatened, or made to feel that one was unloved or worthless
• Sexual abuse – contact sexual abuse by anyone at least five years older, or any adult

Household Dysfunction

• Household substance use – living with someone who had a problem with alcohol or other substances
• Household mental illness – living with someone who was depressed, had a mental illness, or died by suicide
• Domestic violence – witnessing a mother being abused
• Parental separation or divorce
• Incarcerated household member – living with someone who went to prison

Neglect

• Emotional neglect – not feeling loved, important, or special; feeling that family didn’t look out for each other
• Physical neglect – not having enough to eat, wearing dirty clothes, having no one to protect you

Subsequent research has expanded the ACEs framework beyond the original ten categories to include community-level adversities such as poverty, racism, neighborhood violence, food insecurity, and the experience of discrimination – recognizing that the original ACE Study, conducted in a predominantly white, middle-class, college-educated sample, captured only a portion of the adverse experiences that shape child development. These expanded ACEs are sometimes called “community ACEs” or “big-T and small-T” trauma in clinical contexts.

The ACE Study: What Research Found

The original ACE Study enrolled over 17,000 adults in the Kaiser Permanente health system in San Diego and asked them to report on childhood adversities and current health status. The findings were striking – and have since been replicated in dozens of studies worldwide.

More than 60% of adults in the study reported at least one ACE. Nearly 25% reported three or more. ACEs were not rare – they were common, cutting across demographics, and their effects were dose-dependent: more ACEs were associated with substantially higher rates of health and mental health problems across the lifespan.

The study found graded, dose-response relationships between ACE scores and a wide range of adult outcomes – including depression, anxiety, substance use disorders, suicide attempts, heart disease, cancer, liver disease, and early mortality. The more adverse childhood experiences a person had, the higher their statistical risk across virtually every health outcome examined. This was not because ACEs caused disease directly in every case, but because they shaped the biological, psychological, and behavioral pathways through which health is built or eroded over time.

The ACE Study’s findings transformed how researchers and clinicians think about the roots of adult health. Rather than asking “What is wrong with this person?” the ACEs framework asks “What happened to this person?” – a shift that is both scientifically important and humanely significant.

How ACEs Affect the Developing Brain

Childhood is a period of extraordinary neurological development. The brain’s architecture – its stress-response systems, attachment circuitry, emotional regulation networks, and cognitive scaffolding – is shaped profoundly by early experience. When those early experiences include chronic fear, neglect, abuse, or household instability, the developing brain adapts to survive those conditions. These adaptations are intelligent and functional in the short term; they can become sources of difficulty later in life.

Toxic Stress and the HPA Axis

The human stress-response system – centered on the hypothalamic-pituitary-adrenal (HPA) axis – is designed to activate in response to threat and return to baseline when the threat has passed. In children experiencing ACEs, stress is often chronic, unpredictable, and unmitigated by the buffering presence of a safe, responsive adult. This produces what researchers call “toxic stress” – prolonged activation of stress-response systems in the absence of adequate adult support.

Chronic toxic stress in childhood sensitizes the HPA axis, producing lasting changes in the set-point for stress reactivity. Adults with high ACE scores often show elevated baseline cortisol, exaggerated stress responses to mild triggers, and difficulty returning to calm after activation – the neurobiological legacy of a childhood nervous system calibrated for chronic threat.

Amygdala, Hippocampus, and Prefrontal Cortex

Research consistently documents structural and functional brain changes associated with childhood adversity in three key regions:

• Amygdala – the brain’s threat-detection center – shows increased volume and reactivity in individuals with high ACE scores, contributing to heightened fear responses and hypervigilance
• Hippocampus – critical for memory contextualization, learning, and stress regulation – shows reduced volume associated with chronic early stress, contributing to difficulties with memory, learning, and emotional regulation
• Prefrontal cortex – the region governing impulse control, emotional regulation, planning, and executive function – develops more slowly and shows reduced connectivity in individuals who experienced significant early adversity

These changes are not destiny. The brain retains neuroplastic capacity throughout life – the capacity to change, reorganize, and heal in response to new experiences, including effective treatment. But they do help explain why the effects of ACEs often persist into adulthood without specific, trauma-informed intervention.

ACEs and Long-Term Mental Health

The relationship between ACEs and adult mental health is among the most consistently documented findings in psychiatric epidemiology. High ACE scores are associated with substantially elevated risk for:

• Post-traumatic stress disorder (PTSD) and complex PTSD – particularly when ACEs involve abuse, neglect, or chronic household dysfunction
• Major depressive disorder – ACEs are among the most robust predictors of depression onset across the lifespan
• Anxiety disorders – generalized anxiety, social anxiety, panic disorder, and specific phobias are all more prevalent in adults with high ACE scores
• Substance use disorders – the self-medication hypothesis is well supported by ACE data; many individuals with SUDs are managing the psychological consequences of unaddressed childhood trauma
• Eating disorders – ACEs, particularly emotional abuse and neglect, are strongly associated with all eating disorder diagnoses
• Borderline personality disorder – childhood trauma and neglect are among the most consistent findings in the developmental history of BPD
• Suicidality – ACE scores are strongly associated with lifetime suicide attempts, with risk increasing significantly at higher ACE scores

Understanding ACEs does not reduce these conditions to a simple cause-and-effect narrative. Genetics, later life events, social support, and individual resilience factors all matter. But ACEs provide an essential piece of the clinical picture that is often missing when mental health conditions are treated without attention to developmental history.

ACEs and Physical Health

One of the most striking findings of the original ACE Study was the strength of the relationship between childhood adversity and adult physical health outcomes. ACEs are associated with elevated risk for:

• Cardiovascular disease and heart attack
• Stroke
• Diabetes
• Cancer
• Chronic obstructive pulmonary disease (COPD)
• Autoimmune conditions
• Chronic pain
• Obesity
• Early mortality

The mechanisms are multiple: chronic early stress produces lasting changes in immune function, inflammatory signaling, cardiovascular reactivity, and metabolic regulation. Additionally, the coping behaviors that often develop in response to untreated ACE-related psychological distress – substance use, smoking, disordered eating, physical inactivity – are themselves risk factors for many of the same physical health outcomes. The body keeps the score of what happened in childhood, in ways that manifest decades later.

Protective Factors and Resilience

The ACEs framework is sometimes misread as deterministic – as if a high ACE score makes poor health outcomes inevitable. The research does not support this reading. Many individuals with high ACE scores do not develop the associated health problems, and understanding why is as important as understanding the risk.

The most consistently identified protective factor is the presence of at least one stable, safe, responsive adult relationship during childhood – a caregiver, teacher, relative, or other figure who provides consistent emotional support and acts as a buffer against toxic stress. This single factor is among the most powerful moderators of ACE-related risk identified in the literature.

Additional protective factors include:

• Strong social connections and community belonging
• Access to mental health care and trauma-informed treatment
• Stable, safe housing and economic security
• School environments that provide consistency and support
• Individual factors: self-regulation capacity, meaning-making, and the ability to seek and use support

Resilience is not a fixed personality trait some people have and others don’t. It is a dynamic capacity that can be built – through relationships, through treatment, through community – at any point in the lifespan.

Healing from ACEs: What Treatment Can Offer

Adults with high ACE scores can and do heal. The neuroplasticity of the brain means that the adaptations made in response to early adversity can be modified by new experiences – and effective treatment provides those experiences in structured, evidence-based ways.

Trauma-informed care is the foundation of effective ACE-related treatment – an approach that recognizes the pervasive impact of trauma, integrates knowledge about trauma into all aspects of clinical care, and avoids re-traumatization. Within a trauma-informed framework, several specific modalities have strong evidence:

The trauma recovery program at Synchrony Brain Health provides integrated, neuroscience-informed care specifically designed for individuals navigating the long-term effects of childhood trauma and adverse experiences. EMDR therapy – Eye Movement Desensitization and Reprocessing – has one of the strongest evidence bases of any treatment for trauma-related conditions, including those with roots in early childhood adversity. Neurofeedback therapy supports nervous system regulation by directly training the brain’s electrical activity patterns, addressing the hyperarousal and dysregulation that often characterize the neurobiological legacy of ACEs.

Treatment does not erase what happened. But it can change how the past lives in the present – reducing the intensity of trauma symptoms, building regulatory capacity, restoring the ability to feel safe in relationships, and creating the conditions for a meaningful, connected life.

Frequently Asked Questions

What is an ACE score and what does it mean?
An ACE score is a simple count of how many of the ten original adverse childhood experience categories a person experienced before age 18. Scores range from 0 to 10. Research shows a dose-response relationship: higher ACE scores are associated with greater risk across mental and physical health outcomes. However, an ACE score is not a diagnosis or a destiny – it is a tool for understanding developmental history and risk context. Many people with high ACE scores lead healthy, fulfilling lives, particularly with access to adequate support and treatment.

Can ACEs affect you if you don’t remember them?
Yes. Many ACEs – particularly those involving early neglect, household dysfunction, or preverbal trauma – may not be consciously remembered in detail, yet still shape the nervous system’s baseline functioning, attachment patterns, and stress reactivity. The body and nervous system encode experience even when explicit memory does not retain it. This is one reason why trauma-informed treatment addresses physiological and somatic dimensions of experience, not only narrative memory.

Is it too late to heal from ACEs as an adult?
No. The brain retains neuroplastic capacity throughout life – the ability to change, reorganize, and build new patterns in response to new experiences. Adults with high ACE scores can make meaningful progress in therapy, build regulatory capacity, improve relationships, and reduce the physical and psychological burden of early adversity. Healing is not instantaneous or linear, but it is possible at any age and at any point in life.

How do ACEs affect parenting?
Unaddressed ACEs can affect parenting by contributing to difficulties with emotional regulation, attachment security, sensitivity to stress, and the capacity to provide the consistent, responsive caregiving that buffers children from their own adversities. This is not a moral failing – it is a predictable consequence of carrying unresolved trauma into the demands of parenthood. Treatment that addresses a parent’s own ACE history is also an investment in the next generation’s wellbeing. Parenting programs informed by attachment theory and trauma have demonstrated effectiveness in interrupting intergenerational transmission of adversity.

Adverse childhood experiences leave real marks – in the nervous system, in patterns of relating, in the body. But they are not the final word. The clinicians at Synchrony Brain Health in Chicago offer trauma-informed, neuroscience-grounded treatment for adults navigating the long-term effects of childhood adversity. Healing is not about erasing the past – it is about reclaiming your present. A consultation is the first step.

Citations: Felitti, V.J., et al. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14(4), 245–258. Centers for Disease Control and Prevention. (2021). Adverse Childhood Experiences (ACEs). cdc.gov. Shonkoff, J.P., et al. (2012). The lifelong effects of early childhood adversity and toxic stress. Pediatrics, 129(1), e232–e246. McLaughlin, K.A., et al. (2014). Childhood adversity and adult psychiatric disorders in the National Comorbidity Survey Replication II: Associations with persistence of DSM-IV disorders. Psychological Medicine, 42(5), 1–13. van der Kolk, B.A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking. Masten, A.S. (2001). Ordinary magic: Resilience processes in development. American Psychologist, 56(3), 227–238.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. ARFID is a complex eating disorder that requires professional evaluation and individualized care. If you believe you or someone you care about may be experiencing symptoms described here, please consult a qualified mental health or medical professional.

If you or someone you know is struggling with an eating disorder: Contact the National Eating Disorders Association (NEDA) Helpline at 1-800-931-2237, or text “NEDA” to 741741. For a mental health crisis, call or text 988 (Suicide and Crisis Lifeline, available 24/7).

Contents

• What Is ARFID?
• ARFID vs. Picky Eating – What Is the Difference?
• Symptoms and Warning Signs of ARFID
• The Three ARFID Presentations
• What Causes ARFID?
• Who Is Affected by ARFID?
• Medical and Nutritional Consequences
• Treatment for ARFID
• Frequently Asked Questions

ARFID – Avoidant/Restrictive Food Intake Disorder – is an eating disorder characterized by a persistent disturbance in eating that leads to significant nutritional deficiency, dependence on nutritional supplements, weight loss or failure to gain expected weight, and/or marked interference with psychosocial functioning. Unlike other eating disorders such as anorexia nervosa or bulimia nervosa, ARFID is not driven by concerns about body weight or shape. The avoidance or restriction in ARFID is instead rooted in sensory sensitivities, fear of aversive consequences (such as choking or vomiting), or a general lack of interest in eating. First formally recognized in the DSM-5 in 2013, ARFID is a legitimate, often serious condition that is frequently misunderstood as extreme picky eating – a framing that can delay appropriate evaluation and treatment.

What Is ARFID?

According to the DSM-5, ARFID is defined by an eating or feeding disturbance – manifested by persistent failure to meet appropriate nutritional and/or energy needs – associated with one or more of the following:

• Significant weight loss (or failure to achieve expected weight gain or faltering growth in children)
• Significant nutritional deficiency
• Dependence on enteral feeding or oral nutritional supplements
• Marked interference with psychosocial functioning

The disturbance is not better explained by lack of available food, a culturally sanctioned practice, another eating disorder (such as anorexia nervosa), a concurrent medical condition, or another mental health condition – unless the eating disturbance is excessive relative to what would be expected and warrants independent clinical attention.

ARFID was added to the DSM-5 in 2013, replacing the older and more limited category of “Feeding Disorder of Infancy or Early Childhood.” The revision acknowledged that avoidant and restrictive eating patterns causing significant impairment occur across the lifespan – not only in young children – and that the condition deserved recognition as a distinct clinical entity rather than a vague category or a dismissal of “just picky eating.”

ARFID vs. Picky Eating – What Is the Difference?

Many children and some adults are selective about food. Picky eating is common, particularly in early childhood, and typically does not cause significant nutritional deficiency, developmental problems, or meaningful interference with daily life. ARFID is qualitatively different in the degree, persistence, and functional impact of the food avoidance.

Feature	Picky Eating	ARFID
Range of avoided foods	Selective preferences; still eats a reasonably varied diet	Often severely limited; may eat only a handful of specific foods
Nutritional impact	Minimal to none	Often significant – deficiencies in calories, protein, vitamins, minerals
Weight and growth	Typically unaffected	May involve weight loss, failure to gain, or growth faltering in children
Psychosocial impact	Minimal – eats adequately in social situations with some preferences	Significant – avoids social meals, restaurants, school lunch; causes distress
Anxiety around food	Dislike or preference	Often intense fear, disgust, or anticipatory anxiety
Course over time	Often improves naturally with age and exposure	Tends to persist without treatment; may worsen over time

The key clinical question is not whether a person has food preferences, but whether the pattern of avoidance is causing meaningful harm – nutritionally, medically, developmentally, or socially. When it is, professional evaluation is warranted.

Symptoms and Warning Signs of ARFID

ARFID presents differently across individuals, but common signs include:

Behavioral signs:

• Eating only a very limited number of specific foods – sometimes fewer than ten
• Refusing foods based on sensory properties: texture, color, smell, temperature, or appearance
• Gagging, retching, or vomiting in response to non-preferred foods or their proximity
• Extreme difficulty eating at restaurants, school, or social gatherings
• Requiring foods to be prepared in a very specific way and refusing any variation
• Avoiding eating situations entirely to prevent exposure to avoided foods
• Needing nutritional supplements or meal replacement products to maintain adequate intake

Physical signs:

• Weight loss or failure to gain expected weight in children
• Fatigue, pallor, or poor concentration associated with nutritional deficiency
• Delayed growth or development in children
• Nutritional deficiencies identified on lab work

Psychological and social signs:

• Significant anxiety, distress, or panic when presented with non-preferred foods
• Avoidance of social situations involving food – parties, family meals, eating with friends
• Shame, embarrassment, or secrecy about eating patterns
• Impact on quality of life, relationships, and daily functioning disproportionate to typical food preferences

The Three ARFID Presentations

Clinical research and the DSM-5 framework recognize three primary presentations of ARFID, which often overlap and may co-occur in the same individual:

Sensory Sensitivity

The most commonly recognized presentation involves extreme sensitivity to the sensory properties of food – texture, taste, smell, color, or temperature. Many individuals with this presentation describe particular textures as physically intolerable: mushy foods, foods with mixed textures, foods with visible components, or “wet” foods may trigger immediate gag responses or overwhelming disgust. This presentation is most common in people with autism spectrum conditions or sensory processing differences, though it also occurs independently.

Fear of Aversive Consequences

In this presentation, food avoidance is driven by a specific fear of a negative outcome associated with eating – typically choking, vomiting, allergic reaction, or becoming ill. This presentation often develops following a traumatic eating experience: a severe choking episode, a frightening allergic reaction, or a significant illness after eating. The fear becomes conditioned and may generalize to a broader range of foods or eating contexts, even when the original triggering food or situation is no longer present.

Low Interest in Eating

Some individuals with ARFID show a general lack of interest in food and eating – they do not experience hunger in the way others do, forget to eat, feel full very quickly, or simply derive little pleasure or drive from eating. This presentation can be particularly difficult to identify because the person is not distressed about food in an obvious way; they are simply indifferent to it. The result is nonetheless significant: inadequate caloric intake, nutritional deficiency, and impaired functioning.

What Causes ARFID?

ARFID does not have a single cause. Like most eating disorders and mental health conditions, it arises from an interaction of biological, psychological, and developmental factors.

Neurodevelopmental factors: ARFID occurs at significantly elevated rates in individuals with autism spectrum conditions, ADHD, and anxiety disorders. Sensory processing differences – common in autism and some individuals without a formal diagnosis – are strongly implicated in the sensory-sensitivity presentation. Heightened interoceptive awareness, low appetite drive, and rigid cognitive patterns all contribute to vulnerability.

Anxiety: Anxiety disorders, particularly specific phobias and generalized anxiety disorder, frequently co-occur with ARFID and may contribute directly to the fear-of-consequences presentation. The anticipatory anxiety around eating can become so powerful that avoidance behavior is maintained even when the feared outcome is unlikely.

Traumatic eating experiences: A significant choking episode, severe vomiting, a frightening allergic reaction, or a painful gastrointestinal event can serve as a precipitating event for ARFID – particularly in children and adolescents whose fear-conditioning mechanisms are sensitive.

Temperament and early feeding history: Some individuals show food selectivity from very early in life, suggesting a constitutional contribution. Difficult early feeding experiences – prolonged tube feeding, early food refusal, sensory sensitivities in infancy – may establish avoidant patterns that persist and expand over time.

Who Is Affected by ARFID?

ARFID occurs across the lifespan and affects people of all genders, though it is most commonly identified in childhood and adolescence. Unlike anorexia nervosa and bulimia nervosa, which have historically been more prevalent in females, ARFID appears to affect males at higher rates relative to other eating disorders. ARFID is notably prevalent in pediatric populations and among individuals with autism spectrum conditions, where rates of significant food selectivity are substantially elevated.

Adults can also develop ARFID – either as a continuation of childhood-onset food avoidance that was never adequately treated, or as a new-onset condition following a traumatic eating event or a medical illness affecting appetite and eating. In adults, ARFID may be particularly invisible because the affected person has often developed compensatory strategies – eating only at home, avoiding social meals, relying on a narrow set of safe foods – that mask the severity of the impairment from others.

Medical and Nutritional Consequences

When ARFID leads to significant dietary restriction, the medical and nutritional consequences can be serious. Potential complications include:

• Macronutrient deficiency – inadequate protein or caloric intake leading to weight loss or growth impairment
• Micronutrient deficiencies – iron-deficiency anemia, vitamin D deficiency, zinc deficiency, and B-vitamin deficiencies are commonly reported
• Fatigue, cognitive impairment, and poor concentration secondary to nutritional inadequacy
• Bone density concerns with prolonged calcium and vitamin D insufficiency
• In children: delayed growth, developmental concerns, and impaired school performance
• Gastrointestinal symptoms – constipation and limited gut microbiome diversity due to restricted dietary variety

Medical monitoring – including regular weight checks and laboratory assessment of nutritional status – is an important component of Avoidant/Restrictive Food Intake Disorder management, particularly for individuals with severe restriction.

Treatment for ARFID

Treatment for ARFID is individualized and typically involves a multidisciplinary team: a mental health clinician, a dietitian experienced with eating disorders, and – particularly for children – collaboration with the family. There is no single gold-standard treatment for ARFID across all presentations, but evidence-based approaches include:

Cognitive Behavioral Therapy (CBT)

Cognitive behavioral therapy is the most extensively studied psychological treatment for ARFID. CBT for ARFID typically involves psychoeducation about the condition, graduated food exposure (systematic, supported exposure to avoided foods in a structured, low-pressure context), cognitive restructuring targeting catastrophic beliefs about aversive consequences, and relapse prevention planning. The exposure component is carefully paced and collaborative – the goal is to reduce the fear and disgust responses associated with specific foods, not to force eating.

Family-Based Treatment

For children and adolescents with Avoidant/Restrictive Food Intake Disorder, family-based approaches that support caregivers in managing mealtimes, reducing accommodation of avoidant behaviors, and facilitating gradual exposure at home are an important component of treatment. Caregiver psychoeducation helps families understand that the child’s avoidance is driven by genuine distress – not defiance or manipulation – while also supporting the structured change needed for recovery.

Occupational Therapy and Sensory Integration

For individuals with ARFID driven primarily by sensory sensitivities – particularly those with autism spectrum conditions or sensory processing differences – occupational therapy with a sensory integration focus can be a valuable component of treatment. This approach addresses the sensory processing differences that underlie food aversion, building tolerance for a wider range of textures and sensory experiences over time.

Dietetic Support

A registered dietitian experienced in eating disorders plays an essential role in Avoidant/Restrictive Food Intake Disorder treatment: assessing nutritional status, identifying and addressing specific deficiencies, supporting the development of a more varied diet in coordination with the psychological intervention, and managing any necessary nutritional supplementation during the treatment process.

Eating Disorder Specialty Programs

For individuals with more complex presentations – including significant weight loss, medical complications, co-occurring psychiatric conditions, or limited response to outpatient approaches – a higher level of specialized care may be appropriate. Synchrony Brain Health’s Soma-Self eating disorders program provides integrative, trauma-informed care for individuals with eating disorders including ARFID, with a clinical approach that addresses the whole person rather than the food alone.

Frequently Asked Questions

Is ARFID the same as picky eating?
No. Picky eating involves food preferences that do not significantly impair nutrition, growth, or daily functioning. Avoidant/Restrictive Food Intake Disorder is a clinical condition in which food avoidance or restriction causes meaningful harm – nutritional deficiency, weight loss or growth impairment, dependence on supplements, or significant interference with social and daily life. The difference is not in the presence of food preferences, but in whether those preferences are causing clinically significant consequences.

Can adults have ARFID?
Yes. ARFID occurs across the lifespan. Some adults have lived with ARFID since childhood without ever receiving a diagnosis or appropriate treatment. Others develop ARFID in adulthood following a traumatic eating experience, a medical illness, or a significant change in appetite. In adults, ARFID may be less visible because affected individuals have developed extensive compensatory strategies, but the nutritional and psychosocial consequences can be equally significant.

Is ARFID related to autism?
ARFID occurs at substantially elevated rates in individuals with autism spectrum conditions, and sensory processing differences common in autism are strongly associated with the sensory-sensitivity presentation of ARFID. However, ARFID also occurs in individuals without autism. The presence of ARFID does not indicate autism, and the presence of autism does not mean ARFID is inevitable. When both are present, treatment planning should account for both conditions and how they interact.

Will my child outgrow ARFID?
Some food selectivity in early childhood does resolve over time, but Avoidant/Restrictive Food Intake Disorder as a clinical condition – particularly when it involves significant restriction, nutritional consequences, or marked anxiety – does not typically resolve on its own without treatment. Early professional evaluation and intervention are important, both to address current nutritional and health impacts and to prevent the patterns from becoming more entrenched over time. A clinician experienced with feeding and eating disorders can help determine the appropriate level of care.

ARFID is a real, treatable condition – not a parenting failure, a phase, or simple stubbornness. Effective, compassionate treatment exists. The clinicians at Synchrony Brain Health in Chicago offer specialized eating disorder care for individuals and families navigating Avoidant/Restrictive Food Intake Disorder and related conditions. Reaching out for an evaluation is a meaningful first step toward expanded eating and improved quality of life.

Citations: American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Zickgraf, H.F., & Ellis, J.M. (2018). Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): A measure of three restrictive eating patterns. Appetite, 123, 32–42. Norris, M.L., et al. (2014). Exploring avoidant/restrictive food intake disorder in eating disordered patients: A descriptive study. International Journal of Eating Disorders, 47(5), 495–499. Kenney, L., & Walsh, B.T. (2013). Avoidant/restrictive food intake disorder (ARFID): Defining ARFID. Eating Disorders Review, 24(3). National Eating Disorders Association (NEDA). (2022). ARFID. Retrieved from nationaleatingdisorders.org. Sharp, W.G., et al. (2017). Toward a empirical model for ARFID: A review of the behavioral and biologic mechanisms. International Journal of Eating Disorders, 50(12), 1360–1371.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. TMS for OCD requires a comprehensive clinical evaluation to determine appropriateness for each individual. Only a qualified clinician can determine whether TMS is an appropriate treatment option for you. Please consult your mental health provider before making any treatment decisions.

Contents

• What Is OCD?
• How Does TMS Treat OCD? The Brain Science
• Which TMS Device Is FDA-Cleared for OCD?
• What to Expect During TMS Treatment for OCD
• How Effective Is TMS for OCD? What Research Shows
• TMS for OCD vs. Other Treatments
• Who Qualifies for TMS for OCD?
• Frequently Asked Questions

TMS for OCD represents a meaningful advance in treatment options for one of the most challenging psychiatric conditions. Transcranial magnetic stimulation (TMS) is now FDA-cleared for the treatment of obsessive-compulsive disorder – specifically, the BrainsWay deep TMS (dTMS) system using its H7 coil, which received FDA De Novo clearance in 2018. For people with OCD who have not achieved adequate relief from medication and therapy alone, dTMS offers a non-invasive, non-systemic treatment approach that targets the neural circuits underlying OCD directly. No anesthesia is required, there is no systemic medication exposure, and patients can return to daily activities immediately after each session.

What Is OCD?

Obsessive-compulsive disorder (OCD) is a serious, often debilitating psychiatric condition characterized by two core features: obsessions and compulsions.

Obsessions are intrusive, unwanted thoughts, images, or urges that cause marked anxiety or distress. They are persistent and feel difficult or impossible to ignore. Common obsession themes include contamination fears, fears of harming oneself or others, symmetry and exactness concerns, unwanted sexual or religious thoughts, and fears about making catastrophic mistakes.

Compulsions are repetitive behaviors or mental acts performed in response to obsessions – an attempt to neutralize or reduce the anxiety the obsession generates. Common compulsions include washing and cleaning, checking, ordering and arranging, mental reviewing or reassurance-seeking, and counting. The relief from compulsions is temporary; the obsessions return, often with greater intensity, creating a self-reinforcing cycle.

According to the DSM-5, an OCD diagnosis requires that obsessions and/or compulsions are time-consuming (more than one hour per day), cause significant distress, and meaningfully impair daily functioning. OCD affects approximately 2–3% of the general population and is often misunderstood. It is not “being a neat freak” or “being a little OCD.” For many people who live with it, OCD is a serious condition that consumes hours of each day, interferes with relationships and work, and may persist for years or decades if untreated or inadequately treated.

How Does TMS Treat OCD? The Brain Science

Understanding why TMS may help with OCD requires understanding the neuroscience of OCD itself. OCD involves dysregulation in the cortico-striato-thalamo-cortical (CSTC) circuit – a loop connecting the cortex, striatum (including the caudate nucleus), thalamus, and back to the cortex. In OCD, this circuit functions like a car alarm that won’t turn off: it generates an escalating “something is wrong” signal that drives repetitive, compulsive responding.

Key nodes in this circuit include the anterior cingulate cortex (ACC) – involved in error detection and conflict monitoring – and the supplementary motor area (SMA), which plays a role in inhibiting unwanted actions. Neuroimaging research has consistently shown hyperactivity in these regions in people with OCD, and normalization of activity in these regions has been associated with treatment response.

The BrainsWay H7 coil is specifically engineered to reach these deeper cortical and subcortical structures. By delivering repetitive magnetic pulses to the ACC and SMA, dTMS modulates activity in the CSTC circuit – reducing the hyperactivation that drives obsessions and compulsions. The treatment does not eliminate OCD’s neural circuitry; it changes how that circuitry functions, reducing the intensity of the signal that compulsions are attempting to address.

Which TMS Device Is FDA-Cleared for OCD?

FDA Accuracy Note: It is critical to use precise language when discussing FDA regulatory status. “FDA-approved” and “FDA-cleared” have different regulatory meanings. The BrainsWay dTMS H7 system received FDA De Novo clearance for OCD in 2018 – not “FDA approval.” Standard figure-8 TMS coils (used for depression) are not FDA-cleared for OCD. These distinctions matter for accuracy and for patients making informed treatment decisions.

Device / System	Regulatory Status for OCD	Notes
BrainsWay dTMS with H7 coil	FDA De Novo clearance (2018)	The only TMS system specifically FDA-cleared for OCD. Uses deep TMS technology to reach the ACC/SMA.
Standard figure-8 TMS coil (various manufacturers)	FDA-cleared for MDD; NOT cleared for OCD	Some clinicians use standard TMS off-label for OCD. This is legal but does not carry the same regulatory backing as the BrainsWay H7 system for this indication.
BrainsWay dTMS with H1 coil	FDA-cleared for MDD and smoking cessation; NOT for OCD	Different coil geometry; does not target OCD circuits in the same way as the H7.

When evaluating TMS providers for OCD treatment, patients and families should confirm that the provider uses the BrainsWay H7 system – the only configuration with FDA De Novo clearance specifically for OCD. This distinction reflects genuine differences in coil design, stimulation depth, and the evidence base supporting each system for this specific indication.

What to Expect During TMS Treatment for OCD

TMS treatment for OCD follows a structured protocol that differs in one important respect from TMS treatment for depression: the symptom provocation component.

Initial Assessment

Before beginning treatment, a clinical evaluation confirms the OCD diagnosis, reviews prior treatment history (medications, therapy), assesses for contraindications (metal implants near the head, seizure history, pregnancy), and establishes a baseline symptom severity measurement – typically using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).

Symptom Provocation Before Stimulation

A distinctive feature of the FDA-cleared OCD protocol is a brief, clinician-guided symptom provocation component immediately before each TMS session. Before the magnetic stimulation begins, the clinician briefly and gently engages the patient with content related to their OCD – a contamination cue, a checking scenario, or other individually tailored exposure – for approximately 30 seconds. This is designed to engage the specific neural circuits involved in the patient’s OCD at the time of stimulation, so that TMS is applied to an actively engaged circuit rather than a resting one.

This provocation is brief, carefully calibrated, and clinician-guided. It is not a prolonged exposure exercise. For patients unfamiliar with this component, it can sound alarming – but in practice, it involves minimal, controlled, transient discomfort, and is immediately followed by the TMS session itself.

The TMS Session

• The patient is seated comfortably; no sedation or anesthesia is required
• The H7 coil is positioned over the relevant scalp region
• Magnetic pulses are delivered in a pattern determined by the treatment protocol
• Each session typically lasts approximately 20 minutes
• The sensation is commonly described as a tapping or clicking feeling on the scalp; the most common side effect is a mild scalp discomfort or headache that typically resolves shortly after the session

Treatment Course

The clinical trial protocol that supported FDA clearance involved 29 sessions over approximately 6 weeks – a treatment course mirroring the structure of the pivotal trial (Carmi et al., 2019). Patients can drive themselves to and from sessions and return to normal activities immediately afterward. There is no recovery period.

How Effective Is TMS for OCD? What Research Shows

The pivotal clinical trial supporting FDA clearance for TMS for OCD was published by Carmi and colleagues in 2019 in the American Journal of Psychiatry. In this randomized, double-blind, sham-controlled multicenter trial:

• Patients who received active dTMS showed significantly greater reduction in Y-BOCS scores compared to those who received sham (inactive) stimulation
• Response rates (defined as at least 30% reduction in Y-BOCS score) were meaningfully higher in the active treatment group
• The treatment was well tolerated, with the most common adverse event being scalp discomfort at the stimulation site

It is important to contextualize these findings honestly. TMS for OCD is not universally effective – response rates are meaningful but not universal, and individual outcomes vary. TMS is not intended as a standalone treatment for OCD; it is most effective when combined with ongoing psychotherapy, particularly Exposure and Response Prevention (ERP). The International OCD Foundation (IOCDF) notes that TMS represents a significant treatment advance for those with inadequate response to first-line approaches, while emphasizing that ERP remains the behavioral treatment with the strongest evidence base.

TMS for OCD vs. Other Treatments

Treatment	Role in OCD Care	How It Relates to TMS
Exposure and Response Prevention (ERP)	Gold-standard behavioral treatment for OCD; strongest evidence base	TMS works as an adjunct to ERP, not a replacement. The most robust outcomes are achieved when both are used together.
SSRIs (e.g., fluvoxamine, sertraline, fluoxetine)	First-line pharmacological treatment; higher therapeutic doses typically needed for OCD than for depression	TMS is generally indicated for those with partial or inadequate response to at least one adequate SSRI trial
Cognitive Behavioral Therapy (CBT) with ERP	The behavioral component of CBT for OCD is ERP; combined approach is evidence-based	Internal link: cognitive behavioral therapy at Synchrony Brain Health
Spravato / Ketamine	Primarily indicated for treatment-resistant depression (TRD); some individuals with OCD have co-occurring TRD	For individuals with OCD and co-occurring TRD, Spravato/ketamine may be relevant to the broader treatment plan

The OCD treatment landscape has evolved significantly. The standard of care involves ERP as the behavioral backbone, SSRIs as first-line pharmacotherapy, and – for those with inadequate response to these approaches – TMS as an evidence-based adjunctive option. The combination of dTMS and ERP has shown synergistic effects: TMS may reduce the intensity of OCD symptoms enough to make ERP more tolerable and effective for patients who previously found exposure exercises too distressing to complete.

Who Qualifies for TMS for OCD?

TMS for OCD is not appropriate for everyone with OCD – it requires clinical evaluation to determine suitability. General qualifying criteria typically include:

• A confirmed diagnosis of OCD by a qualified clinician
• Inadequate response to at least one adequate trial of an SSRI (at an appropriate dose for a sufficient duration) and a course of ERP therapy
• No absolute contraindications: metallic implants near the head (cochlear implants, certain aneurysm clips, deep brain stimulators), active seizure disorder, or pregnancy
• Ability to participate in the treatment protocol, including the symptom provocation component

A thorough clinical evaluation at Synchrony Brain Health’s dTMS program determines whether dTMS is an appropriate treatment option and, if so, develops an integrated treatment plan that incorporates TMS alongside the psychotherapy and medication management components most likely to support optimal outcomes.

Frequently Asked Questions

Is TMS FDA-approved or just FDA-cleared for OCD?
TMS for OCD is FDA-cleared – not FDA-approved. These are distinct regulatory designations. Specifically, the BrainsWay deep TMS system with its H7 coil received FDA De Novo clearance for OCD in 2018 through a regulatory pathway for novel, low-to-moderate-risk devices. “FDA-approved” and “FDA-cleared” are sometimes used interchangeably in popular usage, but they differ technically. For OCD, the accurate language is “FDA De Novo cleared” or simply “FDA-cleared.” Only the BrainsWay H7 system carries this clearance specifically for OCD.

How many TMS sessions are needed for OCD?
The clinical trial protocol that supported FDA clearance involved 29 sessions delivered over approximately 6 weeks. Individual treatment courses may be adjusted based on clinical response and provider recommendation, but the 29-session, 6-week protocol is the evidence-based standard for dTMS treatment of OCD using the BrainsWay H7 system.

Does TMS for OCD hurt?
TMS for OCD is generally well tolerated. The most commonly reported sensation during treatment is a tapping or clicking feeling at the scalp at the site of stimulation. Mild scalp discomfort or headache following a session is the most common side effect and typically resolves within a few hours. TMS does not require anesthesia and does not involve pain in the conventional sense. The brief symptom provocation before each session involves transient, mild OCD-related discomfort, which patients are prepared for and which resolves quickly.

Can TMS be used with medication for OCD?
Yes. TMS for OCD is typically used in conjunction with ongoing medication (usually an SSRI) and psychotherapy (ERP), not instead of them. The most effective outcomes appear to occur when TMS is part of an integrated treatment plan rather than a standalone intervention. Decisions about medication adjustments during or after TMS should be made in close consultation with a prescribing clinician.

Synchrony Brain Health offers dTMS for qualifying individuals with OCD and other treatment-resistant conditions. If you or someone you care about has not found adequate relief from medication and therapy alone, a clinical evaluation can clarify whether dTMS may be appropriate. The team at Synchrony Brain Health in Chicago includes clinicians experienced in the assessment and treatment of OCD using integrated, evidence-based approaches.

Citations: Carmi, L., et al. (2019). Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. American Journal of Psychiatry, 176(11), 931–938. U.S. Food and Drug Administration. (2018). De Novo classification request for BrainsWay deep TMS system for OCD. FDA DEN170106. International OCD Foundation (IOCDF). (2022). TMS for OCD. Retrieved from iocdf.org. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Rotge, J.Y., et al. (2010). Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. Journal of Psychiatry and Neuroscience, 35(5), 297–306. Greenberg, B.D., et al. (2010). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder. Molecular Psychiatry, 15(1), 64–79.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. While neuroplasticity research offers genuinely hopeful insights into the brain’s capacity for change, it does not suggest that brain-based challenges can be resolved without professional support. Please consult a qualified mental health or medical professional for guidance specific to your situation.

Contents

• What Is Neuroplasticity?
• How Does Neuroplasticity Work?
• Neuroplasticity Across the Lifespan
• Neuroplasticity and Mental Health Conditions
• Therapies and Practices That Harness Neuroplasticity
• Neuroplasticity and Hope in Mental Health Recovery
• Frequently Asked Questions

Neuroplasticity – the brain’s capacity to reorganize its structure, function, and connections in response to experience – is one of the most significant and clinically meaningful discoveries in modern neuroscience. For much of the twentieth century, the dominant assumption was that the adult brain was largely fixed after a critical period of early development: the neurons you had were the neurons you kept, and the circuits they formed were essentially permanent. That assumption has been definitively overturned by decades of research. The brain remains capable of substantial structural and functional change throughout life – in response to learning, experience, injury, therapy, and treatment. Understanding neuroplasticity reframes how we think about mental health treatment: the brain can change, heal, and adapt – and the therapies we use can harness that capacity purposefully.

What Is Neuroplasticity?

Neuroplasticity refers to the ability of neural networks to change through growth, reorganization, and the strengthening or pruning of connections. The term encompasses a range of processes operating at different scales – from changes at individual synapses to large-scale reorganization of functional brain regions.

Two primary forms of neuroplasticity are typically distinguished:

• Structural plasticity: Physical changes in the brain’s architecture – the growth of new synaptic connections, the thickening of dendritic branches, changes in the volume of brain regions, and increased myelination of neural pathways. These changes reflect learning, practice, and adaptation at the cellular level.
• Functional plasticity: Changes in which brain regions take on responsibility for particular functions – most dramatically observed after brain injury, when regions adjacent to damaged areas may assume some of the functions previously handled by the injured tissue.

The historical context matters. Santiago Ramón y Cajal – the Nobel-winning neuroscientist often called the father of modern neuroscience – observed in the early 1900s that adult nerve pathways were “fixed, ended, immutable.” He did suggest the possibility of plasticity but described it as limited. Modern neuroimaging, cellular research, and longitudinal studies have progressively overturned this view. Michael Merzenich, Michael Gazzaniga, and countless others have documented that experience-dependent plasticity is not a curiosity but a central operating feature of the brain throughout the lifespan.

How Does Neuroplasticity Work?

Synaptic Plasticity – Hebbian Learning

The most foundational mechanism of neuroplasticity is synaptic plasticity – changes in the strength of connections between neurons. The principle is often summarized as “neurons that fire together wire together,” a phrase derived from the work of Canadian psychologist Donald Hebb, who proposed in 1949 that repeated co-activation of neurons strengthens the connection between them.

At the cellular level, the key mechanism is long-term potentiation (LTP): the persistent strengthening of synaptic connections following repeated, simultaneous activation. LTP involves changes in the density and sensitivity of receptors at the synapse, and ultimately structural changes to the synaptic apparatus itself. This is how learning, habit formation, and memory consolidation occur at the neurobiological level. It is also the mechanism through which patterns of thinking, emotional responding, and behavioral tendencies become entrenched – and through which they can be changed.

BDNF – The Growth Factor of the Brain

Brain-derived neurotrophic factor (BDNF) is a protein that plays a central role in neuroplasticity. Sometimes described as “fertilizer for the brain,” BDNF promotes the survival of existing neurons, supports the growth of new synaptic connections, and is essential for long-term potentiation. Research has consistently linked higher BDNF levels to better learning, memory, and mood regulation.

BDNF levels are influenced by a range of factors: aerobic exercise reliably increases BDNF, as does sleep, certain psychotherapies, and some pharmacological treatments. Depression and chronic stress are associated with reduced BDNF and hippocampal shrinkage – a relationship that helps explain the cognitive and emotional symptoms of depressive disorders. This BDNF connection is one reason exercise is increasingly recognized not as a lifestyle accessory but as a neurobiologically active intervention in mental health.

Pruning

Neuroplasticity is not only about growth and strengthening – it also involves the elimination of underused connections. Synaptic pruning, particularly active during adolescence, removes neural pathways that are not being used, refining and sharpening the circuits that remain. This “use it or lose it” principle applies across the lifespan: neural pathways that are consistently activated are maintained and strengthened; those that fall into disuse weaken over time. This is why both the reinforcement of adaptive patterns (through practice and therapy) and the interruption of maladaptive patterns are important therapeutic goals.

Neurogenesis

For decades, the dogma was that the adult brain could not generate new neurons. This, too, has been revised. Neurogenesis – the creation of new neurons from neural stem cells – has been convincingly demonstrated in the adult hippocampus, a brain region critically involved in memory formation, emotional regulation, and stress response. Exercise, learning, and reduced chronic stress support hippocampal neurogenesis; chronic stress and depression suppress it. This relationship provides a neurobiological framework for understanding why depression can impair memory and learning – and why effective treatment can restore these capacities.

Neuroplasticity Across the Lifespan

Neuroplasticity is not uniform across the lifespan. The brain is most plastic during critical periods in childhood and adolescence – developmental windows during which experience has an outsized impact on neural architecture. Language, vision, and attachment are among the domains most dramatically shaped by early experience during these sensitive periods.

Adult plasticity is real but operates more slowly and requires greater repetition and effort to produce change compared to the rapid plasticity of early development. This is why learning a new language at 40 is harder than at 4 – not because the adult brain cannot change, but because the mechanisms are less rapid and require more deliberate, sustained practice to produce durable neural reorganization.

Aging brings changes to plasticity mechanisms, including reduced BDNF production and somewhat slower synaptic consolidation. But the “use it or lose it” principle operates throughout old age. Cognitive engagement, social connection, physical activity, and new learning all support maintained plasticity in aging brains. The brain retains the capacity for meaningful change throughout life – a message of genuine hope for people of all ages engaging in mental health treatment.

Neuroplasticity and Mental Health Conditions

Several of the most common mental health conditions involve well-documented neuroplastic changes – alterations in brain structure and function produced by chronic stress, trauma, or sustained emotional dysregulation. Crucially, many of these changes can be reversed or ameliorated by effective treatment.

Trauma and PTSD: Chronic trauma produces measurable neurobiological changes. Research documents amygdala hyperactivation (excessive threat response), reduced hippocampal volume (impairing memory contextualization and stress regulation), and hypoactivity in the medial prefrontal cortex (reducing capacity for top-down regulation of emotional responses). These changes help explain PTSD symptoms – hypervigilance, intrusive memories, emotional dysregulation – as products of neuroplastic adaptation to threat. Effective trauma treatments, including EMDR and trauma-focused CBT, have been shown to partially reverse these changes.

Depression: Major depressive disorder is associated with reduced BDNF, decreased hippocampal volume, and dysregulation in the prefrontal-limbic circuits that govern mood and motivation. Antidepressants, psychotherapy, exercise, and neuromodulation treatments each produce neuroplastic changes – increasing BDNF, supporting hippocampal volume recovery, and normalizing prefrontal-limbic connectivity – that correlate with clinical improvement.

Anxiety: Anxiety disorders involve a sensitized fear circuitry – particularly in the amygdala and its connections to the prefrontal cortex – that generates disproportionate threat responses to low-risk stimuli. Exposure-based psychotherapy works through neuroplastic mechanisms: repeated exposure to feared stimuli without the feared consequence gradually rewires the threat-association, a process called extinction learning. The neural circuits driving excessive fear can be retrained.

Therapies and Practices That Harness Neuroplasticity

Neurofeedback

Neurofeedback therapy directly targets and reshapes brain wave patterns through operant conditioning – rewarding the brain in real time for producing more adaptive patterns of electrical activity. By training specific frequency bands (reducing high-beta hyperarousal, increasing alpha or theta activity in relevant contexts), neurofeedback leverages experience-dependent plasticity to produce durable changes in how the brain regulates itself. It is one of the most direct clinical applications of neuroplasticity principles currently available.

Deep TMS (dTMS)

Deep transcranial magnetic stimulation (dTMS) uses pulsed magnetic fields to non-invasively stimulate targeted neural circuits, inducing neuroplastic changes in brain regions implicated in depression, OCD, and other conditions. Repetitive TMS protocols are thought to produce their therapeutic effects by normalizing activity levels in dysregulated circuits – reducing hyperactivity or increasing hypoactivity, depending on the stimulation parameters – and promoting synaptic plasticity in the targeted regions. The FDA clearance of dTMS for MDD and OCD reflects the growing evidence base for neuromodulation as a tool for harnessing neuroplasticity therapeutically.

EMDR

Eye Movement Desensitization and Reprocessing (EMDR) therapy facilitates the integration of fragmented traumatic memories through bilateral stimulation – allowing the brain to reprocess disturbing experiences and store them as ordinary autobiographical memories rather than intrusive sensory-emotional replays. The neurobiological mechanism is not fully characterized, but hypotheses center on the activation of natural memory reconsolidation processes and normalization of hippocampal-amygdala interactions during memory processing.

Psychotherapy

Structured psychotherapies – CBT, DBT, ACT, and others – produce measurable neuroplastic changes visible on neuroimaging. CBT for depression and anxiety has been shown to normalize prefrontal-amygdala connectivity, reduce amygdala reactivity, and increase activity in prefrontal regulation circuits. These are not merely symptomatic changes – they reflect genuine neurobiological reorganization produced by the sustained cognitive and behavioral practice that therapy involves.

Exercise

Aerobic exercise is among the most well-documented, accessible, and cost-effective neuroplasticity-promoting interventions available. Exercise reliably increases BDNF, promotes hippocampal neurogenesis, reduces amygdala reactivity, increases prefrontal activity, and has demonstrated efficacy as an adjunct treatment in depression and anxiety. The neural mechanisms are real, measurable, and clinically meaningful – supporting the integration of regular physical activity as a component of mental health treatment plans.

Mindfulness / MBSR

Regular mindfulness practice produces structural brain changes documented on neuroimaging: increased cortical thickness in prefrontal regions associated with attention and executive function, reduced amygdala volume associated with reduced reactivity, and increased hippocampal gray matter density. MBSR (Mindfulness-Based Stress Reduction) is the most extensively studied mindfulness-based intervention, with a growing evidence base across anxiety, depression, chronic pain, and stress-related conditions. The neural changes associated with regular mindfulness practice are consistent with the clinical outcomes observed.

Sleep

Sleep is not a passive state – it is the period during which the brain performs critical neuroplastic consolidation work. During sleep, synaptic connections formed during the day are strengthened, pruned, or transferred to long-term storage. The brain’s glymphatic system, most active during deep sleep, clears metabolic waste products including beta-amyloid plaques associated with cognitive decline. Chronic sleep deprivation impairs LTP, reduces BDNF, and disrupts the neuroplastic consolidation processes that learning and recovery depend upon. Sleep is not a luxury in mental health recovery – it is a biological requirement.

Neuroplasticity and Hope in Mental Health Recovery

One of the most profound clinical implications of neuroplasticity research is the reframing it enables. If the brain changes as a result of harmful experiences – chronic stress, trauma, adverse early environments – then it can also change as a result of healing experiences. Treatment, therapy, connection, practice, rest, and intentional engagement with life all produce neuroplastic changes. The brain that was shaped by suffering can be reshaped by care.

Neuroplasticity is the neuroscience of hope. Not a promise that change is easy or instant – it is not. But a well-supported, evidence-based foundation for the possibility of meaningful, lasting change at every stage of life and recovery.

This does not mean that willpower or positive thinking alone can reverse the neurobiological effects of trauma or mental illness. It means that professional treatment – the right interventions, delivered with appropriate expertise – has the potential to produce real, measurable changes in the brain’s structure and function. The work matters. The treatment matters. The brain is listening.

Frequently Asked Questions

Can neuroplasticity reverse trauma damage to the brain?
Research suggests that the neurobiological changes associated with trauma – including reduced hippocampal volume, amygdala hyperactivation, and prefrontal hypoactivity – can be partially to substantially reversed by effective trauma treatment. Studies of EMDR, trauma-focused CBT, and other evidence-based approaches have documented neuroimaging changes consistent with reduced hyperarousal and improved prefrontal regulation after treatment. “Reversal” overstates what is known, but meaningful neurobiological recovery is well-supported by the evidence.

At what age does neuroplasticity stop?
It does not stop. Plasticity is most rapid during developmental critical periods in childhood and adolescence, and more effortful in adulthood, but it continues throughout life. Even in older adults, aerobic exercise has been shown to increase hippocampal volume, and new learning produces measurable structural changes. The brain retains the capacity for neuroplastic change throughout the lifespan.

Does neuroplasticity mean anyone can change their brain?
Neuroplasticity tells us that the brain can change – not that it will do so automatically or without effort and appropriate support. The mechanisms of plasticity require experience, practice, and often professional guidance to activate effectively in the direction of healing. For people dealing with mental health conditions, accessing evidence-based treatment is how neuroplasticity is most likely to be channeled toward recovery. The capacity for change is present; the right conditions must be created to harness it.

What is the fastest way to activate neuroplasticity?
Aerobic exercise has one of the most rapid and well-documented neuroplasticity effects, increasing BDNF within a single exercise session. Sleep, novel learning, and stress reduction all support neuroplastic processes. In clinical contexts, neuromodulation treatments like dTMS can produce targeted neuroplastic changes in specific circuits. There is no single universal “fastest” method – the most effective approach depends on the individual, their condition, and the targeted neural systems involved.

Synchrony Brain Health’s neuroscience-informed treatments – including neurofeedback therapy, dTMS, and MBSR – are designed to harness the brain’s capacity for change in service of lasting mental health recovery. If you are interested in learning how these approaches might support your healing, the clinicians at Synchrony Brain Health in Chicago are available for a consultation.

Citations: Hebb, D.O. (1949). The organization of behavior: A neuropsychological theory. Wiley. Bliss, T.V., & Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit. Journal of Physiology, 232(2), 331–356. Cotman, C.W., & Berchtold, N.C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends in Neurosciences, 25(6), 295–301. van der Kolk, B.A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking. Lazar, S.W., et al. (2005). Meditation experience is associated with increased cortical thickness. NeuroReport, 16(17), 1893–1897. Perera, T.D., et al. (2007). Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. Journal of Neuroscience, 27(18), 4894–4901. DeRubeis, R.J., et al. (2008). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 65(3), 268–276.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Distress tolerance skills are educational tools, not a replacement for professional mental health care. If you are experiencing a mental health crisis, please contact a clinician or emergency services immediately.

If you are in crisis right now: Call or text 988 (Suicide and Crisis Lifeline) – available 24 hours a day, 7 days a week. You can also call 911 or go to your nearest emergency room. Distress tolerance skills are not a substitute for emergency psychiatric care.

 

Contents

• What Is Distress Tolerance?
• Why Distress Tolerance Matters: The Brain in Crisis
• Core Distress Tolerance Skills (DBT)
• Distress Tolerance for Intense Urges
• How to Practice Distress Tolerance
• Frequently Asked Questions

Distress tolerance refers to the ability to endure and survive painful emotional experiences without making the situation worse. It is one of the four core skill modules of Dialectical Behavior Therapy (DBT), developed by Dr. Marsha Linehan – a psychologist whose foundational contributions to the treatment of emotional dysregulation have helped millions of people. The premise of distress tolerance is both honest and compassionate: some pain is unavoidable. Life will contain moments of intense grief, rage, fear, shame, and despair. The goal is not to eliminate these experiences – which is often impossible in the short term – but to get through them without taking actions that add to the suffering. Distress tolerance skills are specifically designed for crisis moments: when emotions are at their peak and wise, values-aligned action feels out of reach.

What Is Distress Tolerance?

Distress tolerance is the capacity to accept and endure acute psychological pain without resorting to impulsive, harmful, or avoidant behaviors that make the situation worse in the long run. In DBT’s framework, it sits alongside emotion regulation, mindfulness, and interpersonal effectiveness as one of four core skill domains.

A key distinction: distress tolerance is not the same as emotion regulation. Emotion regulation involves long-term strategies for changing, reducing, or modulating emotional responses over time. Distress tolerance is for the acute moment – when the emotional intensity is already at a level that makes thoughtful decision-making difficult. Distress tolerance comes first. Once the acute crisis has passed, emotion regulation and problem-solving become available again.

Equally important: distress tolerance is not passive endurance. It is not “just white-knuckle it.” It is an active, strategic set of skills for navigating intense emotional states with intention – reducing physiological arousal, redirecting attention, finding meaning, and choosing not to act on destructive impulses.

Why Distress Tolerance Matters: The Brain in Crisis

When a person is in extreme emotional distress, the prefrontal cortex – the part of the brain responsible for rational thinking, perspective-taking, impulse control, and long-term planning – is functionally compromised. The amygdala, the brain’s threat-response center, is dominant. This is not a weakness or character flaw; it is a neurobiological reality. The person’s capacity to think through consequences, regulate impulses, or access complex cognitive coping strategies is genuinely reduced in this state.

DBT describes this as being in “emotion mind” – a state where decisions are driven primarily by immediate emotional experience, without the tempering of “reasonable mind” (rational, logical thinking). The synthesis of these two – “wise mind” – represents the integration of emotion and reason that allows for values-aligned action. Distress tolerance skills are designed to create a bridge: to reduce the physiological intensity of the crisis state enough that wise mind becomes accessible again.

This is also why distress tolerance skills must be practiced when a person is not in crisis. In the heat of intense distress, the brain cannot learn new skills or access ones that were never rehearsed. Skills practiced regularly in lower-stakes contexts become available as habitual responses when they are most needed.

Core Distress Tolerance Skills (DBT)

TIPP – Rapid Physiological Regulation

TIPP skills address the physiological substrate of intense emotional distress directly – working on the body to create rapid change in arousal levels. This is often the most immediately effective set of skills for acute crisis states because it bypasses cognitive engagement entirely.

T – Temperature: Submerging the face in cold water, holding ice, or applying a cold pack to the forehead and cheeks activates the mammalian dive reflex – a hardwired physiological response that slows heart rate and reduces arousal rapidly. This is one of the fastest-acting distress tolerance techniques available. Effective within 30–60 seconds.

I – Intense Exercise: Brief, vigorous physical activity – running in place, jumping jacks, push-ups – rapidly metabolizes stress hormones and reduces the physiological intensity of emotional distress. Even two minutes of intense movement can produce a measurable shift in emotional state.

P – Paced Breathing: Deliberately slowing and lengthening the exhale activates the parasympathetic nervous system – the body’s rest-and-digest response – and counteracts the fight-or-flight activation of crisis states. A common protocol: inhale for 4 counts, hold for 1, exhale for 6–8 counts. The longer exhale is the key mechanism.

P – Progressive Muscle Relaxation: Systematically tensing and releasing muscle groups throughout the body releases somatic tension and promotes a shift from physiological arousal to relaxation. Particularly useful when the crisis involves a strong somatic component.

ACCEPTS – Distraction with Purpose

ACCEPTS provides a structured approach to temporarily redirecting attention away from the source of distress – buying time for the acute intensity to reduce without acting on it. Unlike unhealthy avoidance, ACCEPTS is used intentionally and temporarily, as a bridge to greater stability.

• A – Activities: Engage in something absorbing – exercise, creative work, puzzles, chores – that fully occupies attention
• C – Contributing: Do something for someone else; shifting focus outward interrupts self-focused rumination
• C – Comparisons: Recall times when you coped well with difficult situations, or acknowledge others who have faced similar or greater hardship with resilience
• E – Emotions (opposite): Intentionally engage with something that evokes a different emotion – a funny video, an uplifting piece of music, a memory that brings comfort
• P – Pushing Away: Temporarily set the problem aside by consciously “placing it on a shelf” to be returned to later – not denial, but a deliberate, time-limited deferral
• T – Thoughts: Redirect attention using a mentally demanding task – counting backwards from 100 by 7s, reciting something from memory, playing a mental word game
• S – Sensations: Use strong but safe sensory experiences to interrupt the distress – intense cold, a sour taste, a strongly scented lotion

Self-Soothe – Engaging the Senses with Comfort

Self-soothe skills involve comforting, non-harmful engagement of each of the five senses to activate the parasympathetic system and reduce distress. The goal is to treat oneself with the same kindness one might extend to a suffering friend:

• Vision: Spending time in nature, looking at art or photography, lighting a candle and watching the flame
• Hearing: Soothing or uplifting music, nature sounds, guided meditation
• Smell: A familiar, comforting scent – a particular tea, fresh air, a scented candle
• Taste: A warm, comforting drink; eating slowly and mindfully rather than eating to numb
• Touch: A warm bath or shower, soft blankets, gentle physical movement

Self-soothe is particularly useful when the crisis involves a sense of being unloved, uncared for, or alone. Deliberate self-compassion in the physical environment can begin to shift this emotional context.

IMPROVE the Moment

IMPROVE provides a set of cognitive and behavioral tools for making the present moment more bearable – not by changing the painful reality, but by changing one’s relationship to it:

• I – Imagery: Visualizing a safe, calming place; imagining the distress as a wave that will pass; guided visualization
• M – Meaning: Finding or creating meaning in the suffering – what is this moment teaching? What does the pain say about what matters?
• P – Prayer: For those for whom it is meaningful, connecting with a sense of something larger than oneself through prayer or spiritual practice
• R – Relaxation: Progressive muscle relaxation, paced breathing, gentle stretching
• O – One thing in the moment: Radical focus on just this moment, this breath, this single task – counteracting the anxiety of all that feels out of control
• V – Vacation: A brief, intentional mental or physical “vacation” from the stressor – a 20-minute walk, a cup of tea in silence
• E – Encouragement: Self-compassionate self-talk: “This is hard. I can get through this. I have survived difficult things before.”

Radical Acceptance

Radical acceptance is perhaps the most philosophically significant distress tolerance skill – and often the most difficult. It involves accepting reality completely and without resistance: not approving of it, not giving up on changing it, but ceasing the battle against the fact of it.

The core insight of radical acceptance: pain is unavoidable; suffering is optional. Suffering, in this framework, arises from the addition of resistance to pain – the “it shouldn’t be this way,” the fighting against what is. When a painful reality cannot be changed in the immediate moment, radical acceptance removes the layer of suffering created by non-acceptance without removing the grief or sadness about the reality itself.

Radical acceptance is an active practice, not a passive attitude. It often requires repeated, conscious choices to accept – and it does not mean that the pain doesn’t matter or that the person doesn’t deserve better. It means recognizing that suffering through non-acceptance will not change the reality, while acceptance frees energy for wise action.

Distress Tolerance for Intense Urges

Distress tolerance skills are frequently used when a person experiences intense urges – including urges toward harmful coping behaviors – during crisis states. TIPP skills (particularly the temperature and intense exercise components) have demonstrated effectiveness as alternatives to harmful coping, providing rapid physiological regulation through safe, non-harmful means.

It is important to understand this in its proper context: distress tolerance skills are a harm-reduction bridge, not a standalone treatment. Recurring crisis states – including persistent urges toward harmful behavior – require professional support to address the underlying conditions that are generating them. If you are regularly experiencing intense urges toward harmful behavior, please reach out to a mental health professional. Distress tolerance skills can help you get through a moment; professional care can help you reduce how often and how intensely those moments occur.

If you are in crisis right now, please call or text 988. You do not have to navigate this alone.

How to Practice Distress Tolerance

The most common reason distress tolerance skills fail in a crisis is that they were not practiced beforehand. The brain under extreme stress reverts to rehearsed patterns. Skills that have never been practiced are not available when the prefrontal cortex is compromised.

Effective practice involves:

• Identifying which skills feel most natural and potentially effective – different skills work better for different people and different types of distress
• Practicing TIPP skills in low-stakes situations to build familiarity with the sensations and sequence
• Creating a personal “crisis plan” that identifies: the earliest warning signs that distress is escalating, the two or three skills most likely to help, and the contacts to reach if skills alone are insufficient

Cognitive behavioral therapy integrates distress tolerance concepts into broader work on cognitive patterns and behavioral responses to distress. MBSR provides the mindfulness foundation that underlies skills like radical acceptance and IMPROVE. For individuals whose crisis states are connected to trauma, trauma recovery program services at Synchrony Brain Health offer the integrated clinical support needed to address the root causes of recurring distress.

Frequently Asked Questions

What is the quickest distress tolerance skill?
The T in TIPP – Temperature – is often the fastest-acting distress tolerance skill. Applying cold water to the face or holding ice engages the mammalian dive reflex, producing a measurable reduction in heart rate and physiological arousal within 30–60 seconds. It requires no cognitive engagement, making it accessible even in states of severe distress when thinking clearly is difficult.

Is radical acceptance giving up?
No. Radical acceptance means accepting the reality of a situation – not approving of it, condoning it, or abandoning efforts to change what can be changed. The distinction is between accepting the present-moment fact of a painful situation and accepting that the situation is okay or permanent. Radical acceptance frees energy from the battle against what cannot be immediately changed, making wise action more possible – not less.

Can I learn distress tolerance without doing full DBT?
Yes. While DBT as a comprehensive program (including individual therapy, skills group, phone coaching, and therapist consultation) offers the most complete treatment approach, the distress tolerance skills themselves can be learned in individual therapy, through psychoeducation, or via DBT skills workbooks. That said, for individuals with significant emotional dysregulation, self-harm history, or borderline personality disorder, the full DBT program is likely to provide the most robust support.

When should I seek professional help instead of using distress tolerance skills?
Distress tolerance skills are designed for managing acute distress – not replacing professional care. Seek professional help immediately if: you are experiencing thoughts of suicide or self-harm, your distress is severe enough to impair basic daily functioning, crisis states are frequent or escalating, or distress tolerance skills are consistently not enough to keep you safe. In an immediate crisis, call 988 or emergency services. Distress tolerance is a bridge; professional care is the foundation.

If distress tolerance skills are not enough in the moment, reaching out to a clinician is the next step. The team at Synchrony Brain Health in Chicago provides DBT-informed care, trauma-informed therapy, and integrated support for individuals navigating chronic or acute emotional distress. Professional support is available – and seeking it is a sign of wisdom, not weakness. If you are in crisis right now, please call or text 988.

Citations: Linehan, M.M. (2014). DBT Skills Training Manual (2nd ed.). Guilford Press. Linehan, M.M. (1993). Cognitive-behavioral treatment of borderline personality disorder. Guilford Press. van Dijk, S. (2012). Calming the emotional storm: Using dialectical behavior therapy skills to manage your emotions and balance your life. New Harbinger Publications. Arntz, A. (2012). Imagery rescripting as a therapeutic technique. Cognitive and Behavioral Practice, 19(4), 640–657. Porges, S.W. (2011). The polyvagal theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation. W.W. Norton & Company.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Substance use disorders and co-occurring mental health conditions require professional evaluation and individualized care. If you or someone you know is in crisis, please call or text 988 (Suicide and Crisis Lifeline) or contact SAMHSA’s National Helpline at 1-800-662-4357 (free, confidential, 24/7).

If you are in immediate crisis or need support right now: Call or text 988 (Suicide and Crisis Lifeline) or call SAMHSA’s National Helpline at 1-800-662-4357 – available 24 hours a day, 7 days a week, in English and Spanish.

Contents

• What Is Relapse Prevention?
• The Three Stages of Relapse
• Warning Signs of Relapse: HALT and Beyond
• Core Relapse Prevention Strategies
• When Relapse Happens
• Relapse Prevention in Dual Diagnosis
• Frequently Asked Questions

Relapse prevention is a set of evidence-based strategies, skills, and plans designed to help people in recovery from substance use disorders recognize warning signs early and build resilience before a crisis point is reached. Focus keyword in the first sentence: relapse prevention is not a single technique but a comprehensive clinical framework developed to address the reality that recovery is rarely a straight line. A return to substance use – often called a relapse – is not a failure of willpower or character. It is a signal that additional support or adjusted tools may be needed. Research from the National Institute on Drug Abuse (NIDA) suggests that relapse rates for substance use disorders are comparable to those of other chronic health conditions like hypertension and diabetes – approximately 40–60% of people in recovery will experience at least one relapse. Understanding the stages of relapse and having a plan in place can interrupt the process long before substance use occurs.

What Is Relapse Prevention?

Relapse prevention as a formalized clinical approach was developed by psychologist G. Alan Marlatt in the 1980s. Building on cognitive-behavioral principles, Marlatt’s model identified that relapse is not a sudden event but a process with identifiable stages, antecedents, and cognitive patterns – all of which create intervention opportunities. The goal of relapse prevention is not simply abstinence but the development of a fulfilling, sustainable life in recovery – one with meaningful connection, coping capacity, and well-being that reduces the motivational pull toward substance use.

Relapse prevention is now integrated into most evidence-based addiction treatment programs. It is applicable across substance types (alcohol, opioids, stimulants, cannabis, and others) and is equally relevant for people in early recovery and long-term recovery. The skills involved – identifying triggers, building coping strategies, creating a support network, developing a personalized plan – serve the person throughout their recovery journey, not just in high-risk moments.

The Three Stages of Relapse

Terence Gorski’s developmental model of relapse describes a predictable progression through three stages before a person returns to substance use. This framework is clinically important because intervention at the earlier stages – before substance use occurs – is significantly more effective than intervention after the fact.

Emotional Relapse

In the emotional relapse stage, the person is not thinking about using. They may be firmly committed to their recovery. But they are engaging in behaviors and emotional patterns that set the stage for later relapse risk. Common indicators include:

• Isolating from support systems – withdrawing from friends, family, or recovery community
• Neglecting self-care: poor sleep, irregular eating, skipping exercise
• Bottling up emotions rather than processing them
• Not being honest with therapists, sponsors, or loved ones about internal state
• Skipping therapy sessions, meetings, or other recovery support activities
• Increasing stress without adequate coping responses

The person in emotional relapse often does not recognize that they are in a vulnerable stage. They may feel that because they are not thinking about using, they are fine. This is precisely what makes emotional relapse the most important stage to recognize and address.

Mental Relapse

In the mental relapse stage, a war begins in the mind. Part of the person wants to stay in recovery; another part begins thinking about using. Common signs include:

• Glamorizing or romanticizing past substance use – remembering the relief or pleasure while minimizing the consequences
• Minimizing how bad things were (“I wasn’t that bad”)
• Bargaining: “I could probably handle just one” or “I’ll just use this once to get through this stressful period”
• Thinking about people, places, or things associated with past use
• Planning opportunities to use, even without fully acknowledging this consciously

Mental relapse is often accompanied by dishonesty – with oneself and with others in the support system. Reaching out to a therapist, counselor, or trusted person in recovery during this stage is among the most effective interventions available.

Physical Relapse

Physical relapse is the actual return to substance use. Once someone picks up, the neurobiological processes underlying addiction – tolerance, craving, reward dysregulation – can rapidly re-engage, particularly for people with opioid or alcohol use disorders. Physical relapse is not inevitable given recognition of earlier stages, and when it does occur, how the person and their support system respond in the immediate aftermath has a significant impact on the trajectory of recovery.

Warning Signs of Relapse: HALT and Beyond

One of the most widely taught relapse prevention frameworks in recovery programs is the HALT acronym: Hungry, Angry, Lonely, Tired. These four states reliably reduce a person’s capacity to cope, deplete self-regulatory resources, and increase vulnerability to cravings and relapse triggers. A regular personal HALT check – asking oneself these four questions – is a simple but powerful self-monitoring practice.

Beyond HALT, broader relapse warning signs to monitor include:

• Increasing stress without adequate support or coping – work, relationship, or financial stress that is escalating without being addressed
• Overconfidence – sometimes called “pink cloud” thinking: the sense that recovery is now so solid that previous supports are no longer necessary
• Relationship conflict – particularly in close relationships, which are often implicated in both the development and maintenance of substance use disorders
• Anniversary dates – the anniversary of a loss, trauma, or significant life event can trigger increased craving without the person immediately recognizing the connection
• Grief and loss – bereavement, relationship endings, job loss, or other significant losses increase relapse vulnerability significantly
• Exposure to use-related cues – visiting locations, people, or situations associated with past use

Personalized trigger awareness – knowing one’s own specific high-risk situations and emotional states – is a core relapse prevention skill. This awareness is developed in therapy and through regular self-reflection practices.

Core Relapse Prevention Strategies

Building a Relapse Prevention Plan

A relapse prevention plan is a written, personalized document developed collaboratively with a therapist or counselor. An effective plan typically includes:

• A clear list of the person’s identified triggers (situational, emotional, interpersonal, and cognitive)
• Personal warning signs – the specific early indicators that the person is entering emotional or mental relapse
• Coping strategies for each category of warning sign
• A tiered list of emergency contacts: support persons, sponsor or peer recovery support, therapist, and crisis line numbers
• A clear statement of what the person will do if they lapse – how to interrupt the lapse before it becomes a full relapse, and who to call immediately

The relapse prevention plan is a living document – it should be revisited and updated as recovery evolves and new challenges emerge.

Coping Skills

In-the-moment coping skills are the practical tools a person can deploy when facing a craving or high-risk situation. Key skills include:

• Urge surfing – a technique from Mindfulness-Based Relapse Prevention (MBRP) that involves observing a craving with curiosity rather than trying to suppress it, recognizing that cravings are time-limited waves that will naturally subside
• HALT response – addressing the underlying state (eat something, express the anger safely, call someone, rest) rather than the craving directly
• Grounding techniques – sensory grounding to return to the present moment and reduce the intensity of craving or anxiety
• Calling a support person – reaching out before using, not after

Lifestyle Balance

Marlatt identified that an unbalanced lifestyle – one dominated by obligations (“should”) with too little authentic self-care and pleasure (“want”) – creates chronic vulnerability to relapse. DBT’s PLEASE skills offer a related framework: treating PhysicaL illness promptly, eating balanced meals, Avoiding mood-altering substances, getting sufficient Sleep, and Exercising regularly. These are not optional lifestyle preferences – they are the biological foundation of emotional regulation and recovery.

Mindfulness-Based Relapse Prevention (MBRP)

MBRP integrates mindfulness meditation practices with cognitive-behavioral relapse prevention skills. Developed by Sarah Bowen and colleagues, MBRP has demonstrated efficacy in reducing both substance use and craving in multiple randomized controlled trials. The central mechanism is developing the capacity to observe cravings and automatic relapse-related thoughts as mental events – not commands that must be obeyed – allowing for a pause between stimulus and response.

CBT Skills

The cognitive-behavioral component of relapse prevention involves identifying and challenging the automatic thoughts and beliefs that maintain relapse risk: “I can’t cope without it,” “One drink won’t hurt,” “I’ve already ruined my recovery so I might as well keep going” (the abstinence violation effect). Cognitive behavioral therapy provides structured tools for examining and testing these thoughts, which over time reduces their power to drive behavior.

Building a Support Network

Social connection is among the most well-documented protective factors in recovery. The support network may include peers in recovery (mutual aid groups such as AA, NA, SMART Recovery), family members who understand addiction, professional support (therapist, counselor, psychiatrist), and, where relevant, peer recovery coaches. Building this network requires honesty about what kind of support is helpful – and sometimes restructuring social relationships that are incompatible with recovery.

When Relapse Happens

A relapse does not erase prior progress. The neurobiological and psychological growth achieved in recovery – the coping skills developed, the self-awareness cultivated, the connections built – remains even after a return to use. Recovery is non-linear, and a slip or relapse is clinical information about what needs adjustment, not a verdict on the person’s worth or capacity for change.

When a relapse occurs, the most important immediate steps are:

1. Reach out immediately – call a therapist, counselor, sponsor, or trusted support person. Do not isolate.
2. Return to treatment – attend the next scheduled appointment, or request an emergency session. Increasing the level of care (e.g., from outpatient to intensive outpatient or residential) may be appropriate.
3. Review the relapse prevention plan – what warning signs were present that were missed or minimized? What triggered the move from mental to physical relapse?
4. Update the plan – use what was learned to strengthen the plan going forward.

The abstinence violation effect – the shame-fueled thought pattern “I’ve already failed, so I might as well keep going” – is one of the most dangerous cognitive patterns following a lapse. Recognizing it as a cognitive distortion, not a truth, is a critical recovery skill.

Relapse Prevention in Dual Diagnosis

For people living with both a substance use disorder and a co-occurring mental health condition – depression, anxiety, PTSD, bipolar disorder, or others – relapse prevention carries additional complexity. Untreated or undertreated mental health symptoms are among the most powerful relapse triggers available. The relationship often runs in both directions: mental health symptoms increase substance use risk, and substance use worsens mental health symptoms.

Effective relapse prevention in dual diagnosis contexts requires integrated treatment that addresses both conditions simultaneously – not sequentially. The REWARD alternative pathways program at Synchrony Brain Health provides this integrated approach, combining neuroscience-informed interventions, psychotherapy, and medication management to support sustainable recovery for people navigating the complexity of co-occurring conditions.

Frequently Asked Questions

What is the HALT acronym in relapse prevention?
HALT stands for Hungry, Angry, Lonely, and Tired – four states that reliably increase relapse vulnerability by depleting the self-regulatory resources needed to manage cravings and make recovery-consistent choices. Regularly checking in with yourself on these four dimensions – and addressing the underlying need directly – is a foundational relapse prevention practice.

Is relapse part of recovery?
Relapse is common in recovery from substance use disorders – NIDA estimates rates of 40–60% for people with SUDs, comparable to other chronic health conditions. This does not mean relapse is inevitable or should be accepted passively. It means that recovery is a process that may involve setbacks, that the risk of relapse can be actively reduced through the strategies described here, and that a relapse is not the end of the recovery story.

What percentage of people in recovery relapse?
According to NIDA, approximately 40–60% of people with substance use disorders will experience at least one relapse during their recovery. These rates are comparable to those of other chronic conditions like hypertension (50–70%) and diabetes (30–50%), underscoring that SUDs are health conditions requiring ongoing management, not personal failures requiring shame.

How do I make a relapse prevention plan?
A relapse prevention plan is best developed with a therapist or counselor who specializes in addiction and recovery. It should include your personal triggers, warning signs (emotional, cognitive, and behavioral), a list of coping strategies matched to specific high-risk situations, a tiered list of people to contact when at risk, and a clear protocol for what to do if a lapse occurs. The plan should be reviewed and updated regularly as your recovery evolves.

Synchrony Brain Health’s REWARD alternative pathways program integrates relapse prevention into comprehensive, personalized recovery care – addressing substance use, co-occurring mental health conditions, and the neurobiological dimensions of addiction together. If you or someone you love is navigating recovery, the clinicians at Synchrony Brain Health in Chicago are available to help.

Citations: Marlatt, G.A., & Gordon, J.R. (1985). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. Guilford Press. National Institute on Drug Abuse. (2020). Drugs, brains, and behavior: The science of addiction. Treatment and recovery. Gorski, T.T., & Miller, M. (1986). Staying sober: A guide for relapse prevention. Herald House/Independence Press. Bowen, S., et al. (2014). Mindfulness-based relapse prevention for addictive behaviors: A clinician’s guide. Guilford Press. SAMHSA. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. HHS Publication No. PEP20-07-01-001.

Educational Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Social anxiety disorder is a diagnosable mental health condition. If you believe you may be experiencing symptoms described here, please consult a qualified mental health professional for a comprehensive evaluation.

Contents

• What Is Social Anxiety Disorder?
• Symptoms of Social Anxiety Disorder
• Social Anxiety vs. Shyness – What Is the Difference?
• What Causes Social Anxiety Disorder?
• Social Anxiety Disorder in Specific Populations
• Treatment for Social Anxiety Disorder
• Frequently Asked Questions

Social anxiety disorder – also known as social phobia – is a persistent, intense fear of social or performance situations in which a person believes they may be scrutinized, embarrassed, or humiliated. It is one of the most common anxiety disorders worldwide, affecting approximately 12% of people at some point in their lifetime. Yet social anxiety disorder is frequently dismissed as “just being shy” or a personality quirk, leaving many people without the recognition and support they need. Social anxiety disorder is qualitatively different from introversion or shyness: it causes significant distress and meaningfully impairs daily functioning – in work, school, relationships, and the basic activities of everyday life.

What Is Social Anxiety Disorder?

According to the DSM-5, social anxiety disorder is characterized by marked fear or anxiety about one or more social situations in which the person is exposed to possible scrutiny by others. The individual fears that they will act in a way – or show anxiety symptoms – that will be negatively evaluated, leading to humiliation, embarrassment, or rejection.

Key diagnostic criteria include:

• Fear or anxiety disproportionate to the actual threat posed by the social situation
• Avoidance of feared situations, or endurance with intense distress
• Symptoms that are persistent, typically lasting six months or longer
• Significant impairment in social, occupational, or other important areas of functioning

It is important to distinguish social anxiety disorder from personality traits that may overlap with it. Social anxiety disorder is not shyness – which is a personality characteristic involving discomfort in unfamiliar settings that typically eases with familiarity. It is not introversion, which reflects a preference for lower-stimulation environments rather than a fear of negative evaluation. And while social anxiety disorder and low self-esteem often co-occur, they are distinct clinical phenomena. The hallmark of social anxiety disorder is the fear of negative evaluation specifically in social or performance contexts – a fear intense enough to impair how a person moves through the world.

Symptoms of Social Anxiety Disorder

Social anxiety disorder produces symptoms across three domains: cognitive, physical, and behavioral. Understanding all three helps explain why the condition can be so pervasive and difficult to manage without professional support.

Cognitive Symptoms

The cognitive dimension of social anxiety disorder is often the most persistent. People with this condition typically experience:

• Intense fear of humiliation or embarrassment – a pervasive expectation that others will judge them negatively
• Excessive self-consciousness – heightened awareness of one’s own behavior, voice, facial expression, or appearance in social situations
• Anticipatory anxiety – dreading upcoming social events for days or weeks beforehand, often to the point of avoidance
• Post-event processing – replaying social interactions afterward, focusing on perceived mistakes or moments of embarrassment, sometimes for hours or days
• Mind-reading – assuming others noticed, judged, or are still thinking about a perceived social misstep

These cognitive patterns maintain and intensify social anxiety over time, even when the feared negative evaluation rarely or never actually occurs.

Physical Symptoms

Social anxiety disorder activates the body’s threat-response system in anticipated or actual social situations. Physical symptoms can include:

• Blushing – one of the most distressing symptoms for many individuals, because it is visible
• Sweating, particularly on the hands or face
• Trembling or shaking
• Nausea or stomach discomfort
• Racing heart (palpitations)
• Voice trembling or stuttering
• Feeling frozen or unable to think clearly

A cruel irony of social anxiety disorder is that these visible physical symptoms often become an additional source of feared negative evaluation – “What if they notice I’m blushing?” – creating a self-reinforcing cycle of anxiety.

Behavioral Symptoms

Behavioral symptoms of social anxiety disorder typically fall into two patterns: avoidance and safety behaviors.

Avoidance involves withdrawing from feared situations altogether – declining social invitations, avoiding public speaking, eating alone rather than in groups, or refusing promotions that involve more interpersonal visibility. While avoidance reduces anxiety in the short term, it prevents the person from learning that feared outcomes rarely materialize, maintaining the disorder over time.

Safety behaviors are subtler strategies used to manage anxiety while technically participating in social situations – checking one’s phone to avoid eye contact, over-rehearsing what to say before speaking, staying close to an exit, or wearing concealing clothing to hide blushing. Safety behaviors, like avoidance, prevent the person from fully testing their feared beliefs, and often inadvertently increase self-focused attention.

Social Anxiety vs. Shyness – What Is the Difference?

The distinction between shyness and social anxiety disorder matters for several practical reasons, including whether professional treatment is indicated.

Feature	Shyness	Social Anxiety Disorder
Nature	Personality trait	Clinical condition
Onset in new situations	Discomfort that typically reduces with familiarity	Fear that persists or intensifies regardless of familiarity
Anticipatory anxiety	Mild or absent	Often severe, days or weeks before events
Post-event processing	Minimal	Prolonged rumination on perceived mistakes
Functional impairment	Minimal to none	Significant – affects work, relationships, daily life
Avoidance	Occasional, situation-specific	Systematic; narrows life over time
Response to professional treatment	Not typically needed	Evidence-based treatment produces meaningful improvement

Many people with social anxiety disorder have been told their whole lives that they are “just shy” – a label that can delay recognition of a treatable condition and inadvertently communicate that the experience is simply a fixed aspect of who they are, rather than something that can improve.

What Causes Social Anxiety Disorder?

Social anxiety disorder arises from an interaction of biological vulnerabilities, temperament, early experiences, and maintaining factors. No single cause explains all cases.

Genetic and biological factors: Social anxiety disorder runs in families, suggesting a heritable component. Neurobiologically, research has consistently found overactivation of the amygdala – the brain’s threat-detection center – in response to social cues in individuals with social anxiety disorder. This hyperreactive threat appraisal system means that faces, eye contact, and social interactions are processed as potentially dangerous in a way that does not occur for people without the condition.

Behavioral inhibition: A temperament style characterized by heightened reactivity to novelty and withdrawal from unfamiliar situations – often visible as early as infancy – is a well-documented developmental precursor to social anxiety disorder. Children with behavioral inhibition are not destined to develop social anxiety disorder, but the trait confers elevated risk.

Negative social experiences: Bullying, public humiliation, chronic criticism, teasing, or relational trauma can contribute to the development of social anxiety disorder, particularly when these experiences occur during developmental periods when identity and social competence are forming.

Parenting patterns: Overprotective parenting that shields a child from social challenge, or highly critical parenting that emphasizes the importance of others’ opinions, may reinforce anxious appraisals of social situations. This is not about assigning blame to caregivers – many of these patterns develop with the intention of protecting the child.

Maintaining factors: Once established, social anxiety disorder is perpetuated by avoidance and safety behaviors that prevent disconfirmation of feared beliefs, as well as the self-focused attention that amplifies awareness of anxiety symptoms. These maintaining factors are precisely what evidence-based treatment targets.

Social Anxiety Disorder in Specific Populations

Social anxiety disorder affects people across genders, ages, and backgrounds, but certain populations warrant specific attention.

Adolescents: Social anxiety disorder most commonly first appears during adolescence – a developmental period defined by heightened social comparison, identity formation, and peer importance. Early identification in this period is important, as untreated social anxiety disorder in adolescence can significantly affect academic and social development.

Gender: Epidemiological studies consistently find social anxiety disorder somewhat more common in women than men, though men with the condition may be less likely to seek help due to stigma around expressing social fear.

ADHD and social anxiety disorder: Social anxiety disorder co-occurs with ADHD at elevated rates. Social mistakes related to impulsivity or inattention in ADHD can generate sufficient negative social feedback to contribute to the development of social anxiety – making differential diagnosis and integrated treatment planning important.

Autism spectrum and social anxiety: Social difficulty is a feature of autism spectrum conditions, but the underlying mechanism differs from social anxiety disorder. In autism, social differences often reflect differences in social processing and communication; in social anxiety disorder, the core driver is fear of negative evaluation. Because the treatment approaches differ substantially, accurate differential diagnosis is essential. A clinician experienced with both conditions should conduct the evaluation.

Treatment for Social Anxiety Disorder

Social anxiety disorder is among the most responsive anxiety disorders to evidence-based treatment. Meaningful improvement is achievable for most people with access to appropriate care.

Cognitive Behavioral Therapy (CBT)

CBT is the gold-standard treatment for social anxiety disorder, with the strongest research support of any intervention. CBT for social anxiety disorder typically involves two core components working together: cognitive restructuring (identifying and challenging the catastrophic thinking patterns that maintain fear) and exposure therapy (gradually and systematically approaching feared social situations until anxiety reduces). Behavioral experiments – structured tests of feared predictions – are particularly effective at disconfirming beliefs like “everyone will think I’m stupid if I say something wrong.” Cognitive behavioral therapy at Synchrony Brain Health is delivered by clinicians trained in evidence-based protocols for anxiety disorders.

Mindfulness-Based Stress Reduction (MBSR)

Mindfulness-based approaches address one of the central maintaining mechanisms in social anxiety disorder: self-focused attention. When someone with social anxiety is in a social situation, attention is directed inward – monitoring blushing, voice trembling, and perceived awkwardness – rather than outward toward the actual social interaction. MBSR trains the capacity to redirect attention and observe thoughts without fusing with them, reducing the intensity of self-monitoring and anticipatory catastrophizing.

Neurofeedback

For individuals whose social anxiety involves significant physiological reactivity, neurofeedback therapy can support nervous system regulation as an adjunct to therapy. By training the brain to shift out of hyperarousal states, neurofeedback may help reduce the physiological substrate of anxiety that makes engaging in exposure-based treatment more difficult.

Medication

SSRIs (selective serotonin reuptake inhibitors) and SNRIs are considered first-line pharmacological treatments for social anxiety disorder and may be used in conjunction with psychotherapy. Beta-blockers are sometimes used for situational performance anxiety – particularly for public speaking or performances – to reduce cardiovascular symptoms. Benzodiazepines are generally not recommended as a primary treatment due to concerns about dependence and their interference with the learning that occurs during exposure therapy. Medication decisions should be made in consultation with a prescribing clinician.

Group Therapy

Group-format therapy is particularly well-suited to social anxiety disorder because the treatment environment itself functions as an exposure context. Practicing social interactions within a supportive group setting, receiving feedback from peers who understand the experience, and witnessing others navigate feared situations provides a uniquely powerful corrective experience that individual therapy alone cannot fully replicate.

Frequently Asked Questions

Is social anxiety disorder the same as introversion?
No. Introversion is a personality trait describing a preference for less socially stimulating environments – it is not associated with fear, distress, or impairment. A person can be introverted without social anxiety, or extroverted with social anxiety. Social anxiety disorder is defined by intense fear of negative evaluation and the functional impairment that results, not by a preference for solitude.

Can social anxiety disorder be overcome without medication?
Many people with social anxiety disorder experience substantial improvement through psychotherapy alone – particularly CBT with exposure therapy. Medication can be a helpful addition, especially for those with more severe symptoms or limited initial response to therapy, but it is not required for everyone. This is a decision best made in conversation with a mental health clinician who can assess your specific situation.

What triggers social anxiety disorder?
Common triggering situations include meeting new people, speaking in groups or in public, being observed while eating or working, starting conversations, attending social events, and situations involving potential judgment or evaluation – such as job interviews or dates. The specific triggers vary between individuals, though fear of negative evaluation is the common thread across triggers.

How do I know if I have social anxiety disorder or just normal shyness?
Consider the following questions: Does the fear persist even in social situations you have experience with? Does anticipatory anxiety begin days or weeks before social events? Do you avoid important opportunities – work, relationships, experiences – because of social fear? Do you replay social interactions afterward, focusing on what went wrong? If these patterns resonate, a professional evaluation by a mental health clinician can provide clarity. Only a qualified clinician can diagnose social anxiety disorder.

Evidence-based treatment for social anxiety disorder can dramatically reduce the fear that limits engagement with work, relationships, and daily life. The clinicians at Synchrony Brain Health in Chicago offer integrated, personalized treatment approaches rooted in the most current evidence. A consultation is a low-stakes first step toward understanding what is possible.

Citations: American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Kessler, R.C., et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. Heimberg, R.G., et al. (2014). Cognitive behavioral therapy for social anxiety disorder: current status and future directions. Behavior Research and Therapy, 62, 1–12. Clark, D.M., & Wells, A. (1995). A cognitive model of social phobia. In R.G. Heimberg et al. (Eds.), Social phobia: Diagnosis, assessment, and treatment. Guilford Press. Kagan, J., & Snidman, N. (1999). Early childhood predictors of adult anxiety disorders. Biological Psychiatry, 46(11), 1536–1541.

Educational Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified mental health professional with any questions you may have regarding a medical condition.

If you are experiencing thoughts of suicide or self-harm: Call or text 988 (Suicide & Crisis Lifeline, available 24/7). Text HOME to 741741 (Crisis Text Line). If you are not sure whether your thoughts are intrusive (ego-dystonic) or active suicidal ideation, a professional assessment is the right next step.

 

Table of Contents

1. What Are Intrusive Thoughts?
2. Why Do Intrusive Thoughts Happen?
3. Intrusive Thoughts vs. Dangerous Thoughts – A Critical Distinction
4. When Intrusive Thoughts Become a Problem
5. How to Cope with Intrusive Thoughts
6. Frequently Asked Questions

Intrusive thoughts are unwanted, involuntary thoughts, images, or impulses that appear in the mind unbidden and often feel disturbing, frightening, or contrary to a person’s values. They are extraordinarily common – research suggests that nearly 94% of people experience intrusive thoughts at some point. The content of an intrusive thought does not reflect a person’s character, values, or true desires. What distinguishes healthy experience from clinical concern is not the thought itself, but how the person relates to it.

If you have been frightened by your own thoughts, this article is for you.

What Are Intrusive Thoughts?

Intrusive thoughts are characterized as ego-dystonic – they feel alien to the person’s sense of self, inconsistent with their values, and unwanted. This distinguishes them from ego-syntonic thoughts, which feel consistent with who one is and what one wants.

Common themes of intrusive thoughts include:

• Thoughts of harming oneself or others, despite having no desire to do so
• Sexual thoughts that feel deeply inconsistent with one’s values or orientation
• Blasphemous or taboo thoughts arising in religious or sacred contexts
• Thoughts about contamination, disease, or danger
• Thoughts about making a terrible mistake or causing catastrophe
• Images of accidents, injury, or violence

The most important thing to understand: having a thought is not the same as wanting to act on it, planning to act on it, or being likely to act on it. The distress that intrusive thoughts cause is, itself, evidence that they are contrary to the person’s values – people are not horrified by thoughts they secretly want.

Why Do Intrusive Thoughts Happen?

The brain is a continuously active, pattern-generating system. Even at rest, it produces an ongoing stream of thoughts, images, and associations – the great majority of which pass unnoticed. Intrusive thoughts represent the mind’s ongoing background processing reaching conscious awareness in a form that captures attention and triggers anxiety.

The paradoxical rebound effect is central to understanding why intrusive thoughts persist: the more a person tries to suppress a thought, the more it rebounds. Research by Daniel Wegner demonstrated this phenomenon with the “white bear” experiment – people instructed not to think about a white bear thought about it more frequently than controls. Attempts to push away intrusive thoughts typically make them more frequent and more distressing.

The brain’s threat-detection system also contributes: thoughts that are associated with fear or perceived danger are tagged for attention and monitoring – a system designed to protect from real threats that, in intrusive thought disorders, applies to thoughts themselves as threats to be monitored and controlled.

Intrusive Thoughts vs. Dangerous Thoughts – A Critical Distinction

Not all disturbing thoughts are intrusive thoughts in the clinical sense. Understanding the distinction between ego-dystonic intrusive thoughts and genuine planning or intent is important:

• Intrusive thoughts are ego-dystonic – they feel horrifying to the person having them. The person does NOT want to act on them and is frightened by their presence.
• Active ideation with intent – such as active suicidal planning or genuine intent to harm another – is qualitatively different. It may feel more aligned with desire, or at least not horrifying in the same way.

This distinction is clinically important and sometimes genuinely difficult to assess. If you are uncertain about the nature of your own thoughts – if you are not sure whether what you are experiencing is intrusive thought or active ideation – a professional assessment is essential. Reaching out to a mental health professional or calling 988 is the appropriate step.

When Intrusive Thoughts Become a Problem

Intrusive Thoughts and OCD

Obsessive-compulsive disorder (OCD) is characterized by intrusive thoughts (obsessions) that trigger significant anxiety, followed by compulsive behaviors or mental rituals performed to neutralize or reduce the anxiety. Common OCD intrusive thought themes include:

• Harm OCD: Intrusive thoughts about harming loved ones, despite having no desire to do so
• Sexual orientation OCD (SO-OCD): Intrusive doubts about one’s sexual identity that feel alien and distressing
• Pedophilia OCD (POCD): Intrusive thoughts related to children – among the most distressing and misunderstood forms of OCD, occurring in people who are absolutely not attracted to children; the horror and distress these thoughts produce is itself diagnostic of their ego-dystonic nature
• Scrupulosity OCD: Religious or moral intrusive thoughts
• Contamination OCD

People with harm OCD, POCD, or other distressing forms of OCD intrusive thoughts are among the most distressed people who seek mental health care – and are among the least likely to act on their thoughts. Their suffering is real and deserves compassionate, non-judgmental, evidence-based treatment.

Intrusive Thoughts and PTSD

Trauma-related intrusive thoughts – unwanted, vivid memories, images, or sensory fragments from traumatic events – are a core symptom of PTSD. These overlap with flashbacks but may also occur as briefer, less immersive intrusions throughout the day.

Intrusive Thoughts and Postpartum Mental Health

Postpartum intrusive thoughts – often involving harm coming to the new baby – are extremely common and are largely normal in new parents. They are almost universally ego-dystonic (horrifying to the parent having them) and are not predictive of harmful behavior. They are often accompanied by intense shame and secrecy. Understanding that these thoughts are common and do not make someone a bad parent is important for seeking appropriate support without fear of judgment.

How to Cope with Intrusive Thoughts

Defusion, not suppression: The most important shift is from fighting or suppressing intrusive thoughts to observing them with distance. Acceptance and Commitment Therapy (ACT) calls this “cognitive defusion” – creating space between the self and the thought rather than fusing with it. Techniques include:

• Labeling: “I am having the thought that…”
• Observing the thought as an event passing through the mind, like weather passing through the sky
• Responding with curiosity rather than alarm: “There’s that thought again”

Exposure and Response Prevention (ERP) is the gold-standard behavioral treatment for OCD-type intrusive thoughts. ERP involves deliberately encountering the feared thought or situation without performing the compulsive neutralizing behavior – allowing the anxiety to naturally reduce (habituation) and learning that the thought does not require action.

Cognitive Behavioral Therapy – including metacognitive therapy approaches – helps modify beliefs about intrusive thoughts themselves: “having this thought means I’m dangerous” is a belief that can be examined and restructured.

EMDR therapy is particularly relevant for trauma-related intrusive thoughts – directly targeting the unprocessed traumatic memories from which intrusive images and fragments originate.

Mindfulness-Based Stress Reduction (MBSR) builds the non-judgmental present-moment awareness that allows intrusive thoughts to be observed without the escalating anxiety response that makes them persist.

Frequently Asked Questions

Are intrusive thoughts a sign of mental illness?

Not necessarily. Research shows that approximately 94% of people without any mental health diagnosis experience intrusive thoughts. The presence of intrusive thoughts alone is not a sign of mental illness. What distinguishes clinical presentations like OCD is not the thoughts themselves but the degree of distress they cause, the person’s relationship to them (believing they must be controlled or acted on), and the compulsive responses they trigger. If intrusive thoughts are causing significant distress or impairment, professional evaluation is appropriate.

Can intrusive thoughts indicate I will act on them?

Research consistently shows that the content of intrusive thoughts is not predictive of behavior. Ego-dystonic intrusive thoughts – thoughts that feel alien and horrifying – are characterized by the person’s strong desire NOT to act on them. People with harm OCD, for example, go to extraordinary lengths to avoid any situation that might bring them near the content of their intrusions. The distress the thoughts cause is evidence of their ego-dystonic nature, not of danger.

What is the difference between intrusive thoughts and obsessions?

In clinical usage, “obsessions” refer specifically to the recurring intrusive thoughts that are characteristic of OCD – they are persistent, cause significant anxiety, and drive compulsive behaviors. “Intrusive thoughts” is a broader term that encompasses the normal (nearly universal) experience of unwanted thoughts as well as clinically significant presentations. All obsessions are intrusive thoughts, but not all intrusive thoughts constitute obsessions.

Why do my intrusive thoughts feel so real?

The vividness and emotional intensity of intrusive thoughts is partly a function of how strongly they are resisted – fighting a thought amplifies it. It also reflects the brain’s ability to generate rich, detailed imagery. Intrusive thoughts, particularly in OCD and PTSD, may feel compelling or real in part because the brain’s threat-detection system has marked them as important. Treatment helps change the relationship to this experience so that the thoughts can be observed without the escalating amplification of alarm.

Professional Support for Intrusive Thoughts

If intrusive thoughts are causing significant distress or interfering with your daily life, professional support can help. Synchrony Brain Health offers evidence-based care for OCD, anxiety, and trauma-related conditions – including the compassionate, non-judgmental approach that distressing intrusive thoughts require.

This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Citations: Rachman, S., & de Silva, P. (1978). Abnormal and normal obsessions. Behaviour Research and Therapy; Clark, D.A. (2004). Intrusive Thoughts in Clinical Disorders; Wegner, D.M. (1989). White Bears and Other Unwanted Thoughts; IOCDF – International OCD Foundation.

Educational Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified mental health professional with any questions you may have regarding a medical condition.

If you or someone you know is in crisis: Call or text 988 (Suicide & Crisis Lifeline, available 24/7). For medical emergencies, call 911.

 

Important: Alcohol withdrawal can be life-threatening and requires medical supervision. Do not attempt to stop heavy, regular alcohol use abruptly without medical guidance. Seek medical evaluation before attempting to stop drinking if you are physically dependent.

Table of Contents

1. What Is Alcohol Use Disorder?
2. Signs and Symptoms of AUD
3. Alcohol Withdrawal – A Medical Emergency
4. What Causes Alcohol Use Disorder?
5. How Is AUD Diagnosed?
6. Treatment for Alcohol Use Disorder
7. Recovery from Alcohol Use Disorder
8. Frequently Asked Questions

Alcohol use disorder (AUD) is a chronic brain condition characterized by an impaired ability to control alcohol consumption despite significant negative consequences. The modern term replaces older language like “alcoholism” and “alcohol dependence” – a shift that reflects scientific understanding: AUD involves measurable changes in brain structure and function that make stopping genuinely difficult, even when a person strongly wants to. It is not a moral failing. It is treatable.

Understanding what alcohol use disorder actually is – what distinguishes it from heavy or risky drinking, how it develops, and what effective treatment looks like – can be the foundation for making informed decisions about getting help.

What Is Alcohol Use Disorder?

The DSM-5 defines alcohol use disorder as a problematic pattern of alcohol use leading to clinically significant impairment or distress, with at least 2 of 11 criteria present within a 12-month period. Severity is specified as:

• Mild AUD: 2–3 criteria
• Moderate AUD: 4–5 criteria
• Severe AUD: 6 or more criteria

AUD is not defined primarily by how much someone drinks, but by the pattern of drinking – the consequences, the loss of control, and the continued use despite problems. A person can have AUD without drinking every day; and a person can drink heavily without meeting AUD criteria.

Signs and Symptoms of AUD

The DSM-5 organizes the 11 criteria into clinically meaningful clusters. These are presented here as educational information – only a qualified clinician can make a diagnosis.

Impaired Control

• Drinking more, or for longer, than originally intended
• Persistent desire or repeated unsuccessful efforts to cut down or control drinking
• Spending a great deal of time obtaining alcohol, drinking, or recovering from its effects
• Craving – a strong urge or desire to drink

Social Consequences

• Recurrent failure to fulfill major obligations at work, school, or home due to drinking
• Continued drinking despite persistent interpersonal problems caused or worsened by alcohol
• Giving up or reducing important activities – social, occupational, recreational – because of drinking

Hazardous Use

• Recurrent drinking in physically hazardous situations
• Continuing to drink despite knowing that alcohol is causing or worsening a physical or psychological problem

Physiological Dependence

• Tolerance: Needing markedly more alcohol to achieve the same effect, or noticeably diminished effect with the same amount
• Withdrawal: Experiencing characteristic alcohol withdrawal symptoms when alcohol use is reduced or stopped (see below)

Alcohol Withdrawal – A Medical Emergency

Alcohol withdrawal is uniquely dangerous among substance withdrawal syndromes. Unlike opioid or stimulant withdrawal (which are extremely uncomfortable but rarely fatal), alcohol withdrawal can cause serious and life-threatening complications in individuals who are physically dependent.

Withdrawal symptoms typically begin 6–24 hours after the last drink and may progress in severity:

• Mild/early: Tremors, sweating, anxiety, headache, nausea, elevated heart rate and blood pressure
• Moderate: Hallucinations (auditory or visual), confusion, marked agitation
• Severe: Seizures (typically within 12–48 hours), delirium tremens (DTs) – a potentially fatal syndrome involving confusion, severe autonomic instability, and hallucinations, typically occurring 48–72 hours after the last drink

Anyone with significant physical alcohol dependence who is planning to stop drinking should seek medical evaluation and supervision. Do not attempt to stop drinking abruptly without medical guidance.

What Causes Alcohol Use Disorder?

AUD develops through the interaction of multiple factors:

• Genetic factors: AUD is 40–60% heritable. Having a first-degree relative with AUD significantly elevates risk.
• Neurobiological factors: Alcohol affects the GABA (inhibitory) and glutamate (excitatory) neurotransmitter systems, as well as the dopamine reward pathway. Chronic alcohol use causes the brain to adapt – upregulating glutamate and downregulating GABA – creating the neurological basis for withdrawal.
• Trauma and adverse experiences: Adverse childhood experiences (ACEs) are strongly correlated with AUD; many people use alcohol to manage unprocessed trauma symptoms, including hyperarousal, insomnia, and emotional dysregulation.
• Co-occurring mental health conditions: Depression, anxiety, PTSD, and ADHD frequently co-occur with AUD, often in a bidirectional relationship where each worsens the other.
• Social and environmental factors: Peer norms, cultural attitudes toward drinking, availability, and socioeconomic stress all contribute.

How Is AUD Diagnosed?

Alcohol use disorder is diagnosed through a comprehensive clinical evaluation. Validated screening tools – including the AUDIT (Alcohol Use Disorders Identification Test) and the CAGE questionnaire – can provide useful initial information, but clinical diagnosis requires a professional evaluation that reviews DSM-5 criteria, medical history, and co-occurring conditions.

A comprehensive clinical assessment is particularly important given how frequently AUD co-occurs with depression, anxiety, PTSD, and other conditions that require integrated treatment.

Treatment for Alcohol Use Disorder

Alcohol use disorder is treatable, and recovery is possible. The most effective treatment addresses both the neurobiological and psychosocial dimensions of the condition.

Behavioral treatments:

• Cognitive Behavioral Therapy (CBT) – identifies and changes the thought and behavior patterns that maintain alcohol use; develops coping skills for triggers and high-risk situations
• Motivational Enhancement Therapy (MET) – builds intrinsic motivation for change through an empathic, non-confrontational approach
• Twelve-Step Facilitation – supports engagement with AA and mutual aid recovery communities

Medication-assisted treatment (MAT):

• Several FDA-approved medications can support AUD recovery by reducing cravings or altering alcohol’s effects. These include naltrexone, acamprosate, and disulfiram. Medication decisions should always be made in consultation with a prescribing clinician who can evaluate appropriateness for the individual’s specific circumstances.

Neurofeedback may be used as an adjunctive approach to support nervous system regulation and address the dysregulated brain patterns associated with chronic alcohol use and co-occurring conditions.

Synchrony Brain Health’s REWARD Program provides integrated, evidence-based care for alcohol use disorder, including comprehensive assessment, behavioral treatment, and coordinated medical care.

Recovery from Alcohol Use Disorder

Recovery from alcohol use disorder is possible and well-documented. Long-term remission rates with appropriate treatment are meaningful – particularly when treatment addresses co-occurring conditions and when ongoing support is maintained.

Recovery is not always linear. Many people in recovery experience periods of difficulty or relapse – and relapse does not erase prior progress. It is a signal that more support or adjusted strategies are needed, not evidence that recovery is impossible. Multiple pathways to recovery exist – including abstinence-based and harm-reduction approaches – and the most effective path is one the person can sustain and finds meaningful.

Frequently Asked Questions

What is the difference between alcoholism and alcohol use disorder?

“Alcoholism” is an informal, non-clinical term that has largely been replaced in clinical and research contexts by “alcohol use disorder” – language that reflects the current neuroscientific understanding of the condition, reduces stigma, and captures the spectrum of severity rather than implying an all-or-nothing distinction.

How do I know if I have a drinking problem?

The most important indicators are not how much you drink, but rather whether drinking is causing problems in your life – in relationships, work, health, or functioning – and whether you’ve found yourself unable to cut back or stop when wanting to. If you’re asking the question, speaking with a qualified clinician who can conduct a proper assessment is the most reliable next step.

Is AUD genetic?

Genetic factors account for approximately 40–60% of AUD risk. Family history is a significant risk factor. However, genetics is not destiny – many people with a strong family history never develop AUD, and environmental factors, trauma, and mental health play important roles. AUD develops through the interaction of biological vulnerability with life experiences.

Can you drink again after recovering from AUD?

This is a complex and highly individualized question that is best answered in consultation with a clinician who knows your specific history. For many people with severe AUD, particularly those with significant physical dependence, abstinence is the most sustainable and medically appropriate path. Some harm-reduction frameworks support controlled drinking as a treatment goal for less severe presentations. There is no universal answer – the safest approach should be determined with professional guidance.

Integrated Care for Alcohol Use Disorder

Synchrony Brain Health offers integrated assessment and evidence-based care for alcohol use disorder, including comprehensive evaluation, behavioral treatment, and coordination of medical care. If you or someone you care about is struggling with alcohol, reaching out for a clinical consultation is the most important first step.

This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Citations: DSM-5 (APA, 2013); NIAAA – Alcohol Use Disorder: A Comparison Between DSM-IV and DSM-5; SAMHSA – Treatment of Alcohol Problems: A Resource Manual; Grant, B.F., et al. (2015). Epidemiology of DSM-5 alcohol use disorder. JAMA Psychiatry.